CONSOLIDATED STATEMENTS OF CONDITION (Parenthetical) - USD ($) |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Investment securities: | ||
| Held-to-maturity, allowance for credit Loss | $ 0 | $ 0 |
| Available-for-sale, allowance for credit loss | $ 0 | $ 0 |
| Stockholders' Equity | ||
| Preferred stock, authorized (in shares) | 5,000,000 | 5,000,000 |
| Preferred stock, issued (in shares) | 0 | 0 |
| Common stock, authorized (in shares) | 30,000,000 | 30,000,000 |
| Common stock, issued (in shares) | 16,285,786 | 16,158,413 |
| Common stock, outstanding (in shares) | 16,285,786 | 16,158,413 |
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) - $ / shares |
3 Months Ended | |
|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
| Statement of Stockholders' Equity [Abstract] | ||
| Cash dividends paid on common stock (in dollars per share) | $ 0.25 | $ 0.25 |
Basis of Presentation |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Basis of Presentation | Basis of Presentation The consolidated financial statements include the accounts of Bancorp, a bank holding company, and its wholly-owned bank subsidiary, Bank of Marin, a California state-chartered commercial bank. References to “we,” “our,” “us” mean Bancorp and the Bank that are consolidated for financial reporting purposes. The accompanying unaudited consolidated interim financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and note disclosures normally included in annual financial statements prepared in accordance with U.S. generally accepted accounting principles ("GAAP") have been condensed or omitted pursuant to those rules and regulations. Although we believe that the disclosures are adequate and the information presented is not misleading, we suggest that these interim financial statements be read in conjunction with the annual financial statements and the notes thereto included in our 2023 Annual Report on Form 10-K. In the opinion of management, the unaudited consolidated financial statements reflect all adjustments, which are necessary for a fair presentation of the consolidated financial position, the results of operations, changes in comprehensive income (loss), changes in stockholders’ equity, and cash flows for the periods presented. All material intercompany transactions have been eliminated. The results of these interim periods may not be indicative of the results for the full year or for any other period. The following table shows: 1) weighted average basic shares, 2) potentially dilutive weighted average common shares related to stock options and unvested restricted stock awards, and 3) weighted average diluted shares. Basic earnings per share (“EPS”) are calculated by dividing net income by the weighted average number of common shares outstanding during each period, excluding unvested restricted stock awards. Diluted EPS are calculated using the weighted average number of potentially dilutive common shares. The number of potentially dilutive common shares included in the quarterly diluted EPS is computed using the average market prices during the three months included in the reporting period under the treasury stock method. The number of potentially dilutive common shares included in year-to-date diluted EPS is a year-to-date weighted average of potentially dilutive common shares included in each quarterly diluted EPS computation. In computing diluted EPS, we exclude anti-dilutive shares such as options whose exercise prices exceed the current common stock price, as they would not reduce EPS under the treasury stock method. We have two forms of outstanding common stock: common stock and unvested restricted stock awards. Holders of unvested restricted stock awards receive non-forfeitable dividends at the same rate as common shareholders and they both share equally in undistributed earnings. Under the two-class method, the difference in EPS is nominal for these participating securities.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Recently Adopted and Issued Accounting Standards |
3 Months Ended |
|---|---|
Mar. 31, 2024 | |
| Accounting Policies [Abstract] | |
| Recently Adopted and Issued Accounting Standards | Recently Adopted and Issued Accounting Standards Accounting Standards Adopted in 2024 In June 2022, the FASB issued ASU No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. The amendment reduces diversity in practice by clarifying that a separate contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. In addition, this ASU provided amended examples to illustrate that a restriction that is a characteristic of the equity security, which market participants would take into account when pricing them, would be considered in measuring fair value. This ASU also introduced new disclosure requirements. The amendments were effective prospectively for years beginning after December 15, 2023. As discussed in Note 4, Investment Securities, in 2023 we sold our remaining shares of Visa Inc. Class B restricted common stock. As a result of the sale, this update had no impact our financial condition, results of operations or disclosures. In March 2023, the FASB issued ASU No. 2023-01, Leases (Topic 842): Common Control Arrangements. For public companies, the amendment requires entities to amortize leasehold improvements associated with common control lease arrangements over the useful life of the improvements to the common control group, as opposed to the shorter of the remaining lease term and the useful life of the improvements for all other operating leases. The amendments were effective for years beginning after December 15, 2023, and may be adopted either prospectively or retrospectively. We currently do not have common control lease arrangements, and therefore the adoption of the amendments had no impact on our financial condition, results of operations or disclosures. In March 2023, the FASB issued ASU No. 2023-02, Investments—Equity Method and Joint Ventures (Topic 323): Accounting for Investments in Tax Credit Structures Using the Proportional Amortization Method. Under current GAAP, an entity can only elect to apply the proportional amortization method to investments in low-income housing tax credit ("LIHTC") structures. The proportional amortization method results in the cost of the investment being amortized in proportion to the income tax credits and other income tax benefits received, with the amortization of the investment and the income tax credits being presented net in the consolidated statements of income as a component of income tax expense (benefit). The amendments will allow entities to elect to account for all other equity investments made primarily for the purpose of receiving income tax credits to using the proportional amortization method, regardless of the tax credit program through which the investment earns income tax credits, when certain conditions are met. The amendments were effective for fiscal years beginning after December 15, 2023, and may be adopted either on a modified retrospective basis or retrospectively. Other than investments in LIHTC funds, as disclosed in Note 4, Investment Securities, we currently have no other equity investments made primarily for the purpose of receiving income tax credits, and therefore the adoption of this ASU had no impact on our financial condition, results of operations or disclosures. Accounting Standards Not Yet Effective In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments are intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses, enhanced interim disclosure requirements, clarifying circumstances in which an entity can disclose multiple segment measures of profit or loss, providing new segment disclosure requirements for entities with a single reportable segment, and requiring other disclosures. The amendments are effective for annual reporting periods beginning after December 15, 2023 (i.e., 2024 Form 10-K) and interim periods within fiscal years beginning after December 31, 2024, and shall be applied retrospectively to all prior periods presented in the financial statements. Early adoption is permitted. We currently have only one reportable segment and are evaluating the impact the amendments will have on our financial statement disclosures upon adoption. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments require disaggregated information about the effective tax rate reconciliation and additional disclosures on reconciling items and taxes paid that meet a quantitative threshold. The amendments are effective for annual reporting periods beginning after December 15, 2024, and may be adopted either prospectively or retrospectively. Early adoption is permitted. We are currently evaluating the impact of the amendments on our financial statement disclosures upon adoption.
|
Fair Value of Assets and Liabilities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value of Assets and Liabilities | Fair Value of Assets and Liabilities Fair Value Hierarchy and Fair Value Measurement We group our assets and liabilities that are measured at fair value into three levels within the fair value hierarchy, based on the markets in which the assets and liabilities are traded and the reliability of the assumptions used to determine fair value. These levels are: Level 1: Valuations are based on unadjusted quoted prices in active markets for identical assets or liabilities. Level 2: Valuations are based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuations for which all significant assumptions are observable or can be corroborated by observable market data. Level 3: Valuations are based on unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Values are determined using pricing models and discounted cash flow models and may include significant management judgment and estimation. Transfers between levels of the fair value hierarchy are recognized through our monthly and/or quarterly valuation process in the reporting period during which the event or circumstances that caused the transfer occurred. No such transfers occurred in the years presented. The following table summarizes our assets and liabilities that were required to be recorded at fair value on a recurring basis.
1 Other comprehensive income ("OCI") or net income ("NI"). Available-for-sale securities are recorded at fair value on a recurring basis. When available, quoted market prices (Level 1) are used to determine the fair value of available-for-sale securities. Level 1 securities include U.S. Treasury securities. If quoted market prices are not available, we obtain pricing information from a reputable third-party service provider, who may utilize valuation techniques that use current market-based or independently sourced parameters, such as bid/ask prices, dealer-quoted prices, interest rates, benchmark yield curves, prepayment speeds, probability of default, loss severity and credit spreads (Level 2). Level 2 securities include obligations of state and political subdivisions, U.S. agencies or government-sponsored agencies' debt securities, mortgage-backed securities, government agency-issued securities, and corporate bonds. As of March 31, 2024 and December 31, 2023, there were no Level 3 securities. Held-to-maturity securities may be subject to an allowance for credit losses as a result of our evaluation of expected losses due to credit quality factors. We did not record any credit loss expense on held-to-maturity securities during the three months ended March 31, 2024 or March 31, 2023. Fair value of held-to-maturity securities is determined using the same techniques discussed above for available-for-sale securities. On a recurring basis, derivative financial instruments are recorded at fair value, which is based on the income approach using observable Level 2 market inputs, reflecting market expectations of future interest rates as of the measurement date. Standard valuation techniques are used to calculate the present value of the future expected cash flows assuming an orderly transaction. Valuation adjustments may be made to reflect both our own credit risk and the counterparties’ credit risk in determining the fair value of the derivatives. These unobservable inputs are not considered significant inputs to the fair value measurement overall. Level 2 inputs for the valuations are limited to observable market prices for Secured Overnight Financing Rate ("SOFR") and Overnight Index Swap ("OIS") rates (for the very short term), quoted prices for SOFR futures contracts, observable market prices for SOFR and OIS swap rates, and one-month and three-month SOFR basis spreads at commonly quoted intervals. Mid-market pricing of the inputs is used as a practical expedient in the fair value measurements. We project spot rates at reset days specified by each swap contract to determine future cash flows, then discount to present value using OIS curves as of the measurement date. When the value of any collateral placed with counterparties is less than the interest rate derivative liability, a credit valuation adjustment ("CVA") is applied to reflect the credit risk we pose to counterparties. We have used the spread between the Standard & Poor's BBB rated U.S. Bank Composite rate and SOFR for the closest maturity term corresponding to the duration of the swaps to derive the CVA. Because there is little to no counterparty risk, we did not incorporate credit adjustments from our assessment of the counterparty credit risk in determining fair value. For further discussion on our methodology for valuing our derivative financial instruments, refer to Note 9, Derivative Financial Instruments and Hedging Activities. Certain financial assets may be measured at fair value on a non-recurring basis. These assets are subject to fair value adjustments that result from the application of the lower of cost or fair value accounting or write-downs of individual assets, such as individually analyzed loans that are collateral dependent and other real estate owned ("OREO").
Disclosures about Fair Value of Financial Instruments The table below is a summary of fair value estimates for financial instruments as of March 31, 2024 and December 31, 2023, excluding financial instruments recorded at fair value on a recurring basis (summarized in the first table in this note). The carrying amounts in the following table are recorded in the consolidated statements of condition under the indicated captions. Further, we have not disclosed the fair value of financial instruments specifically excluded from disclosure requirements such as bank-owned life insurance policies ("BOLI"), lease obligations and non-maturity deposit liabilities. Additionally, we held shares of Federal Home Loan Bank ("FHLB") of San Francisco stock at cost as of March 31, 2024 and December 31, 2023. There were no impairments or changes resulting from observable price changes in orderly transactions for the identical or similar investments of the same issuer as of March 31, 2024 or December 31, 2023. See further discussion on values within Note 4, Investment Securities.
The fair value of loans is based on exit price techniques and obtained from an independent third-party that uses its proprietary valuation model and methodology and may differ from the actual price from a prospective buyer. The discounted cash flow valuation approach reflects key inputs and assumptions that are unobservable, such as loan probability of default, loss given default, prepayment speed, and market discount rates. The fair value of fixed-rate time deposits is estimated by discounting future contractual cash flows using discount rates that reflect the current observable market rates offered for time deposits of similar remaining maturities. The value of off-balance-sheet financial instruments is estimated based on the fee income associated with the commitments, which in the absence of credit exposure, is considered to approximate their settlement value. The fair value of commitment fees was not material as of March 31, 2024 or December 31, 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment Securities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investment Securities | Investment Securities Our investment securities portfolio consists of U.S. Treasury securities, obligations of state and political subdivisions, U.S. federal government agencies, such as the Government National Mortgage Association ("GNMA") and Small Business Administration ("SBA"), and U.S. government-sponsored enterprises ("GSEs"), such as the Federal National Mortgage Association ("FNMA"), Federal Home Loan Mortgage Corporation ("FHLMC"), Federal Farm Credit Banks Funding Corporation and FHLB, and U.S. Corporations. We also invest in residential and commercial mortgage-backed securities (“MBS”/"CMBS") and collateralized mortgage obligations (“CMOs”) issued or guaranteed by the GSEs, as reflected in the following table. A summary of the amortized cost, fair value and allowance for credit losses related to securities held-to-maturity as of March 31, 2024 and December 31, 2023 is presented below.
Management measures expected credit losses on held-to-maturity securities collectively by major security type with each type sharing similar risk characteristics, and considers historical credit loss information that is adjusted for current conditions and reasonable and supportable forecasts. With regard to MBSs and CMOs issued or guaranteed by the GSEs, and SBA-backed securities, we expect to receive all the contractual principal and interest on these securities as such securities are backed by the full faith and credit of and/or guaranteed by the U.S. government. Accordingly, no allowance for credit losses has been recorded for these securities. With regard to securities issued by states and political subdivisions and corporate bonds, management considers: (i) issuer and/or guarantor credit ratings, (ii) historical probability of default and loss given default rates for given bond ratings and remaining maturity, (iii) whether issuers continue to make timely principal and interest payments under the contractual terms of the securities, (iv) internal credit review of the financial information, and (v) whether or not such securities have credit enhancements such as guarantees, contain a defeasance clause, or are pre-refunded by the issuers. Based on the comprehensive analysis, no credit losses are expected. The following table summarizes the amortized cost of our portfolio of held-to-maturity securities issued by states and political subdivisions and corporate bonds by Moody's and/or Standard & Poor's bond ratings as of March 31, 2024 and December 31, 2023.
A summary of the amortized cost, fair value and allowance for credit losses related to securities available-for-sale as of March 31, 2024 and December 31, 2023 is presented below.
The amortized cost and fair value of investment debt securities by contractual maturity at March 31, 2024 and December 31, 2023 are shown below. Expected maturities may differ from contractual maturities if the issuers of the securities have the right to call or prepay obligations with or without call or prepayment penalties.
There were no sales of investment securities in the first quarter of 2024 or 2023.
The reported values of pledged investment securities are shown in the following table.
There were 317 and 313 securities in unrealized loss positions at March 31, 2024 and December 31, 2023, respectively. Those securities are summarized and classified according to the duration of the loss period in the tables below:
As of March 31, 2024, the investment portfolio included 306 investment securities that had been in a continuous loss position for twelve months or more and 11 investment securities that had been in a loss position for less than twelve months. Securities issued by government-sponsored agencies, such as FNMA and FHLMC, usually have implicit credit support from the U.S. federal government. However, since 2008, FNMA and FHLMC have been under government conservatorship and, therefore, contractual cash flows for these investments carry explicit guarantees by the U.S. federal government while FNMA and FHLMC remain under conservatorship. Securities issued by the SBA and GNMA have explicit credit guarantees by the U.S. federal government, which protects us from credit losses on the contractual cash flows of the securities. Our investments in obligations of state and political subdivision bonds are deemed creditworthy after our comprehensive analysis of the issuers' latest financial information, credit ratings by major credit agencies, and/or credit enhancements. No allowances for credit losses have been recognized on available-for-sale securities in an unrealized loss position, as management does not believe any of the securities are impaired due to credit risk factors at either March 31, 2024 or December 31, 2023. In addition, for any available-for-sale securities in an unrealized loss position at March 31, 2024 and December 31, 2023, the Bank assessed whether it intended to sell the securities, or if it was more likely than not that it would be required to sell the securities before recovery of its amortized cost basis, which would require a write-down to fair value through net income. Because the Bank did not intend to sell those securities that were in an unrealized loss position, and it was not more-likely-than-not that the Bank would be required to sell the securities before recovery of their amortized cost bases, the Bank determined that no write-down was necessary as of the reporting date. On July 7, 2023, the Bank entered into various interest rate swap agreements with notional values totaling $101.8 million to hedge balance sheet interest rate sensitivity and protect selected securities in its available-for-sale portfolio against changes in fair value related to changes in the benchmark interest rate. For additional details, refer to Note 9, Derivative Financial Instruments and Hedging Activities. Non-Marketable Securities Included in Other Assets FHLB Capital Stock As a member of the FHLB, we are required to maintain a minimum investment in FHLB capital stock as determined by the Board of Directors of the FHLB. The minimum investment requirements can increase in the event we increase our total asset size or borrowings with the FHLB. Shares cannot be purchased or sold except between the FHLB and its members at the $100 per share par value. We held $16.7 million of FHLB stock included in other assets on the consolidated statements of condition at both March 31, 2024 and December 31, 2023. The carrying amounts of these investments are reasonable estimates of fair value because the securities are restricted to member banks and they do not have a readily determinable market value. Based on our analysis of FHLB's financial condition and certain qualitative factors, we determined that the FHLB stock was not impaired at March 31, 2024 and December 31, 2023. On April 25, 2024, FHLB announced a cash dividend for the first quarter of 2024 at an annualized dividend rate of 8.25% to be distributed in mid-May 2024. Cash dividends paid on FHLB capital stock are recorded as non-interest income. For further information, refer to Note 8, Commitments and Contingencies. Low Income Housing Tax Credits We invest in low-income housing tax credit funds as a limited partner, which totaled $1.9 million and $2.0 million recorded in other assets as of March 31, 2024 and December 31, 2023, respectively. In the first three months of 2024, we recognized $133 thousand of low-income housing tax credits and other tax benefits, offset by $111 thousand of amortization expense of low-income housing tax credit investment, as a component of income tax expense. As of March 31, 2024, our unfunded commitments for these low-income housing tax credit funds totaled $343 thousand. We did not recognize any impairment losses on these low-income housing tax credit investments during the first three months of 2024 or 2023, as the value of the future tax benefits exceeds the carrying value of the investments.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loans and Allowance for Credit Losses on Loans |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Receivables [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Loans and Allowance for Credit Losses on Loans | Loans and Allowance for Credit Losses on Loans The following table presents the amortized cost of loans by portfolio class as of March 31, 2024 and December 31, 2023.
1 Amortized cost includes net deferred loan origination costs of $2.6 million and $2.7 million at March 31, 2024 and December 31, 2023, respectively. Amounts are also net of unrecognized purchase discounts of $1.9 million and $2.0 million at March 31, 2024 and December 31, 2023, respectively. Amortized cost excludes accrued interest, which totaled $6.3 million and $6.6 million at March 31, 2024 and December 31, 2023, respectively, and is included in in the consolidated statements of condition. Lending Risks Commercial and Industrial Loans - Commercial loans are generally made to established small and mid-sized businesses to provide financing for their growth and working capital needs, equipment purchases and acquisitions. Management examines historical, current, and projected cash flows to determine the ability of the borrower to repay obligations as agreed. Commercial loans are made based primarily on the identified cash flows of the borrower and secondarily on the underlying collateral and guarantor support. The cash flows of borrowers, however, may not occur as expected, and the collateral securing these loans may fluctuate in value. Most commercial and industrial loans are secured by the assets being financed, such as accounts receivable and inventory, and typically include personal guarantees. We target stable businesses with guarantors who provide additional sources of repayment and have proven to be resilient in periods of economic stress. A weakened economy, and resultant decreased consumer and/or business spending, may have an effect on the credit quality of commercial loans. Commercial Real Estate Loans - Commercial real estate loans, which include income producing investment properties and owner-occupied real estate used for business purposes, are subject to underwriting standards and processes similar to commercial loans discussed above. We underwrite these loans to be repaid from cash flow from either the business or investment property and supported by real property collateral. Underwriting standards for commercial real estate loans include, but are not limited to, debt coverage and loan-to-value ratios. Furthermore, a large majority of our loans are guaranteed by the owners of the properties. Conditions in the real estate markets or downturn in the general economy may adversely affect our commercial real estate loans. In the event of a vacancy, we expect guarantors to carry the loans until they find a replacement tenant. The owner's substantial equity investment provides a strong economic incentive to continue to support the commercial real estate projects. As such, we have generally experienced a relatively low level of loss and delinquencies in this portfolio. Construction Loans - Construction loans are generally made to developers and builders to finance construction, renovation and occasionally land acquisitions in anticipation of near-term development. Construction loans include interest reserves that are used for the payment of interest during the development and marketing periods and are capitalized as part of the loan balance. When a construction loan is placed on nonaccrual status before the depletion of the interest reserve, we apply the interest funded by the interest reserve against the loan's principal balance. These loans are underwritten after evaluation of the borrower's financial strength, reputation, prior track record, and independent appraisals. We monitor all construction projects to determine whether they are on schedule, completed as planned and in accordance with the approved construction budgets. Significant events can affect the construction industry, including: the inherent volatility of real estate markets and vulnerability to delays due to weather, change orders, inability to obtain construction permits, labor or material shortages, and price changes. Estimates of construction costs and value associated with the completed project may be inaccurate. Repayment of construction loans is largely dependent on the ultimate success of the project. Consumer Loans - Consumer loans primarily consist of home equity lines of credit, other residential loans, floating homes, and indirect luxury auto loans, along with a small number of installment loans. Our other residential loans include tenancy-in-common fractional interest loans ("TIC") located almost entirely in San Francisco County. We originate consumer loans utilizing credit score information, debt-to-income ratio and loan-to-value ratio analysis. Diversification among consumer loan types, coupled with relatively small loan amounts that are spread across many individual borrowers, mitigates risk. We do not originate sub-prime residential mortgage loans, nor is it our practice to underwrite loans commonly referred to as "Alt-A mortgages," the characteristics of which are reduced documentation, borrowers with low FICO scores or collateral with high loan-to-value ratios. Credit Quality Indicators We use a risk rating system to evaluate asset quality, and to identify and monitor credit risk in individual loans, and in the loan portfolio. Our definitions of “Special Mention” risk graded loans, or worse, are consistent with those used by the Federal Deposit Insurance Corporation ("FDIC"). Our internally assigned grades are as follows: Pass and Watch - Loans to borrowers of acceptable or better credit quality. Borrowers in this category demonstrate fundamentally sound financial positions, repayment capacity, credit history and management expertise. Loans in this category must have an identifiable and stable source of repayment and meet the Bank’s policy regarding debt-service-coverage ratios. These borrowers are capable of sustaining normal economic, market or operational setbacks without significant financial consequences. Negative external industry factors are generally not present. The loan may be secured, unsecured or supported by non-real estate collateral for which the value is more difficult to determine and/or marketability is more uncertain. This category also includes “Watch” loans, where the primary source of repayment has been delayed. “Watch” is intended to be a transitional grade, with either an upgrade or downgrade within a reasonable period. Special Mention - Potential weaknesses that deserve close attention. If left uncorrected, those potential weaknesses may result in deterioration of the payment prospects for the asset. Special Mention assets do not present sufficient risk to warrant adverse classification. Substandard - Inadequately protected by either the current sound worth and paying capacity of the obligor or the collateral pledged, if any. A Substandard asset has well-defined weaknesses that jeopardize the liquidation of the debt. Substandard assets are characterized by the distinct possibility that we will sustain some loss if such weaknesses or deficiencies are not corrected. Well-defined weaknesses include adverse trends or developments of the borrower’s financial condition, managerial weaknesses and/or significant collateral deficiencies. Doubtful - Critical weaknesses that make collection or liquidation in full improbable. There may be specific pending events that work to strengthen the asset; however, the amount or timing of the loss may not be determinable. Pending events generally occur within one year of the asset being classified as Doubtful. Examples include: merger, acquisition, or liquidation; capital injection; guarantee; perfecting liens on additional collateral; and refinancing. Such loans are placed on non-accrual status and usually are collateral-dependent. We regularly review our credits for accuracy of risk grades whenever we receive new information and at each quarterly and year-end reporting period. Borrowers are generally required to submit financial information at regular intervals. Typically, commercial borrowers with lines of credit are required to submit financial information with reporting intervals ranging from monthly to annually depending on credit size, risk and complexity. In addition, investor commercial real estate borrowers with loans exceeding a certain dollar threshold are usually required to submit rent rolls or property income statements annually. We monitor construction loans monthly. We review home equity and other consumer loans based on delinquency. We also review loans graded “Watch” or worse, regardless of loan type, no less than quarterly. The following tables present the loan portfolio by loan portfolio class, origination/renewal year and internal risk rating as of March 31, 2024 and December 31, 2023. The current year vintage table reflects gross charge-offs by loan portfolio class and year of origination. Generally, existing term loans that were re-underwritten are reflected in the table in the year of renewal. Lines of credit that have a conversion feature at the time of origination, such as construction to perm loans, are presented by year of origination.
The following table shows the amortized cost of loans by portfolio class, payment aging and non-accrual status as of March 31, 2024 and December 31, 2023.
2 None of the non-accrual loans as of March 31, 2024 or December 31, 2023 were earning interest on a cash or accrual basis. We reversed $10 thousand in accrued interest income for loans that were placed on non-accrual status during the three months ended March 31, 2024. We reversed accrued interest income of $16 thousand for loans that were placed on non-accrual status during the three months ended March 31, 2023. Collateral Dependent Loans The following table presents the amortized cost basis of individually analyzed collateral-dependent loans, which were all on non-accrual status, by portfolio class at March 31, 2024 and December 31, 2023.
1 There were no collateral-dependent residential real estate mortgage loans in process of foreclosure or in substance repossessed at March 31, 2024 and December 31, 2023. The weighted average loan-to-value of real estate secured collateral dependent loans was approximately 82% at March 31, 2024 and 70% at December 31, 2023. Loan Modifications to Borrowers Experiencing Financial Difficulty The following table summarizes the amortized cost of loans as of March 31, 2024 that were modified during the three months ended March 31, 2024 by portfolio class and type of modification granted. There were no modifications of loans during the three months ended March 31, 2023 requiring disclosure.
As of March 31, 2024, there were no unfunded loan commitments for loans that were modified during the period presented. The following table summarizes the financial effect of loan modifications presented in the table above during the three months ended March 31, 2024 by portfolio class.
The loan modifications did not significantly impact the determination of the allowance for credit losses on loans during the three months ended March 31, 2024. The Bank closely monitors the performance of the modified loans to understand the effectiveness of its modification efforts. The following table summarizes the amortized cost and payment status of loans as of March 31, 2024 that were modified during the three months ended March 31, 2024 by portfolio class.
There were no loans that defaulted (fully or partially charged-off or became 90 days or more past due) that were modified during the three months ended March 31, 2024. Allocation of the Allowance for Credit Losses on Loans The following table presents the details of the allowance for credit losses on loans segregated by loan portfolio class as of March 31, 2024 and December 31, 2023.
Allowance for Credit Losses on Loans Rollforward The following table discloses activity in the allowance for credit losses on loans for the periods presented.
Pledged Loans Our FHLB line of credit is secured under terms of a blanket collateral agreement by a pledge of certain qualifying loans with unpaid principal balances of $1.299 billion and $1.288 billion at March 31, 2024 and December 31, 2023, respectively. In addition, we pledge eligible TIC loans, which totaled $108.5 million and $110.4 million at March 31, 2024 and December 31, 2023, respectively, to secure our borrowing capacity with the Federal Reserve Bank ("FRB"). For additional information, see Note 6, Borrowings. Related Party Loans The Bank has, and expects to have in the future, banking transactions in the ordinary course of its business with directors, officers, principal shareholders and their businesses or associates. These transactions, including loans, are granted on substantially the same terms, including interest rates and collateral on loans, as those prevailing at the same time for comparable transactions with persons not related to us. Likewise, these transactions do not involve more than the normal risk of collectability or present other unfavorable features. The following table shows changes in net loans to related parties for each of the three years ended March 31, 2024. Related party loans totaled $5.8 million as of both March 31, 2024 and December 31, 2023. In addition, undisbursed commitments to related parties totaled $212 thousand as of both March 31, 2024 and December 31, 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Borrowings and Other Obligations |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Borrowings and Other Obligations | Borrowings and Other Obligations Federal Home Loan Bank: The Bank had lines of credit with the FHLB totaling $951.2 million and $1.009 billion as of March 31, 2024 and December 31, 2023, respectively, based on eligible collateral of certain loans and investment securities. Federal Funds Lines of Credit: The Bank had unsecured lines of credit with correspondent banks for overnight borrowings totaling $125.0 million and $135.0 million as of March 31, 2024 and December 31, 2023, respectively. In general, interest rates on these lines approximate the federal funds target rate. Federal Reserve Bank: The Bank had a line of credit through the Discount Window at the Federal Reserve Bank of San Francisco ("FRBSF") totaling $350.0 million as of March 31, 2024, secured by investment securities and residential loans. As of December 31, 2023, the Bank had a line of credit through the Discount Window totaling $64.0 million, secured by residential loans, and a $270.2 million line under the Federal Reserve's temporary Bank Term Funding Program ("BTFP") based on the par values of pledged investment securities. When the BTFP program ended on March 11, 2024, the investment securities were used to collateralize borrowings through the Discount Window. Other Obligations: Finance lease liabilities totaling $260 thousand and $298 thousand as of March 31, 2024 and December 31, 2023, respectively, are included in in the consolidated statements of condition. Refer to Note 8, Commitments and Contingencies, for additional information. The carrying values and weighted average interest rates on borrowings and other obligations as of March 31, 2024 and December 31, 2023 are summarized in the following table.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stockholders' Equity | Stockholders' Equity Dividends On January 25, 2024, Bancorp declared a $0.25 per share cash dividend, paid February 15, 2024 to shareholders of record at the close of business on February 8, 2024. Subsequent to quarter end on April 25, 2024, Bancorp declared a $0.25 per share cash dividend, payable on May 16, 2024 to shareholders of record at the close of business on May 9, 2024. Share-Based Payments The fair value of stock options as of the grant date is recorded as stock-based compensation expense in the consolidated statements of comprehensive income over the requisite service period, which is generally the vesting period, with a corresponding increase in common stock. Stock-based compensation also includes compensation expense related to the issuance of restricted stock awards. The grant-date fair value of the restricted stock awards, which equals the grant date price, is recorded as compensation expense over the requisite service period with a corresponding increase in common stock as the shares vest. Stock options and restricted stock awards issued include a retirement eligibility clause whereby the requisite service period is satisfied at the retirement eligibility date. For those awards, we accelerate the recording of stock-based compensation when the award holder is eligible to retire. However, retirement eligibility does not affect the vesting of restricted stock or the exercisability of the stock options, which are based on the scheduled vesting period. Performance-based stock awards (restricted stock) are issued to a selected group of employees. Stock award vesting is contingent upon the achievement of pre-established long-term performance goals set by the Compensation Committee of the Board of Directors. Performance is measured over a three-year period and cliff vested. These performance-based stock awards were granted at a maximum opportunity level, and based on the achievement of the pre-established goals, the actual payouts can range from 0% to 200% of the target award. For performance-based stock awards, an estimate is made of the number of shares expected to vest based on the probability that the performance criteria will be achieved to determine the amount of compensation expense to be recognized. The estimate is re-evaluated quarterly and total compensation expense is adjusted for any change in the current period. We record excess tax benefits (deficiencies) resulting from the exercise of non-qualified stock options, the disqualifying disposition of incentive stock options and vesting of restricted stock awards as income tax benefits (expense) in the consolidated statements of comprehensive income with a corresponding decrease (increase) to current taxes payable. The holders of unvested restricted stock awards are entitled to dividends on the same per-share ratio as holders of common stock. Tax benefits for dividends paid on unvested restricted stock awards are recorded as tax benefits in the consolidated statements of comprehensive income with a corresponding decrease to current taxes payable. Dividends on forfeited awards are included in stock-based compensation expense. Stock options and restricted stock may be net settled in a cashless exercise by a reduction in the number of shares otherwise deliverable upon exercise or vesting in satisfaction of the exercise payment and/or applicable tax withholding requirements. Shares withheld under net settlement arrangements are available for future grants. The table below depicts the total number of shares, amount, and weighted average price withheld for cashless exercises for the periods presented.
Share Repurchase Program On July 21, 2023, the Board of Directors approved the adoption of Bancorp's new share repurchase program for up to $25.0 million and expiring on July 31, 2025. There have been no repurchases to date in 2024 or in 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingent Liabilities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Commitments and Contingent Liabilities | Commitments and Contingent Liabilities Financial Instruments with Off-Balance Sheet Risk We make commitments to extend credit in the normal course of business to meet the financing needs of our customers. These financial instruments include commitments to extend credit in the form of loans or through standby letters of credit. Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require payment of a fee. Because various commitments will expire without being fully drawn, the total commitment amount does not necessarily represent future cash requirements. Our credit loss exposure is equal to the contractual amount of the commitment in the event of nonperformance by the borrower. We use the same credit underwriting criteria for all credit exposure. The amount of collateral obtained, if deemed necessary by us, is based on management's credit evaluation of the borrower. Collateral types pledged may include accounts receivable, inventory, other personal property and real property. The contractual amount of unfunded loan commitments and standby letters of credit not reflected in the consolidated statements of condition are as follows:
We record an allowance for credit losses on unfunded loan commitments at the balance sheet date based on estimates of the probability that these commitments will be drawn upon according to historical utilization experience of the different types of commitments and expected loss rates determined for pooled funded loans. The allowance for credit losses on unfunded commitments totaled $1.1 million at both March 31, 2024 and December 31, 2023, which is included in interest payable and other liabilities in the consolidated statements of condition. There was no provision for credit losses on unfunded loan commitments in the first quarter of 2024. The $174 thousand reversal of the provision for credit losses on unfunded loan commitments in the first quarter of 2023 was due primarily to a $37.4 million decrease in total unfunded commitments. Leases We lease premises under long-term non-cancelable operating leases with remaining terms of 30 days to 18 years, 5 months, most of which include escalation clauses and one or more options to extend the lease term, and some of which contain lease termination clauses. Lease terms may include certain renewal options that were considered reasonably certain to be exercised. We lease certain equipment under finance leases with initial terms of 3 years to 5 years. The equipment finance leases do not contain renewal options, bargain purchase options or residual value guarantees. The following table shows the balances of operating and finance lease right-of-use assets and lease liabilities.
The following table shows supplemental disclosures of noncash investing and financing activities for the periods presented.
The following table shows components of operating and finance lease cost.
The following table shows the future minimum lease payments, weighted average remaining lease terms, and weighted average discount rates under operating and finance lease arrangements as of March 31, 2024. The discount rates used to calculate the present value of lease liabilities were based on the collateralized FHLB borrowing rates that were commensurate with lease terms and minimum payments on the lease commencement date.
Litigation Matters Bancorp may be party to legal actions that arise from time to time in the normal course of business. Bancorp's management is not aware of any pending legal proceedings to which either it or the Bank may be a party or has recently been a party that will have a material adverse effect on the financial condition or results of operations of Bancorp or the Bank. The Bank is responsible for a proportionate share of certain litigation indemnifications provided to Visa U.S.A. ("Visa") by its member banks in connection with Visa's lawsuits related to anti-trust charges and interchange fees ("Covered Litigation"). We sold our remaining shares on July 13, 2023, however our proportionate share of the litigation indemnification liability does not change or transfer upon the sale of our Class B Visa shares to member banks or, per the terms of the sale, to the recent purchaser of our shares. Visa established an escrow account for the Covered Litigation that it periodically funds, which is expected to cover the settlement payment obligations. Litigation is ongoing and until the court approval process is complete, there is no assurance that Visa will resolve the claims as contemplated by the amended class settlement agreement, and additional lawsuits may arise from individual merchants who opted out of the class settlement. However, until the escrow account is fully depleted and the conversion rate of Class B to Class A common stock is reduced to zero, no future cash settlement payments are required by the member banks, such as us, on the Covered Litigation. Therefore, we are not required to record any contingent liabilities for the indemnification related to the Covered Litigation, as we consider the probability of losses to be remote.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Financial Instruments and Hedging Activities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative Financial Instruments and Hedging Activities | Derivative Financial Instruments and Hedging Activities The Bank is exposed to certain risks from both its business operations and changes in economic conditions. As part of our asset/liability and interest rate risk management strategy, we may enter into interest rate derivative contracts to modify repricing characteristics of certain of our interest-earning assets and interest-bearing liabilities. The Bank generally designates interest rate hedging agreements utilized in the management of interest rate risk as either fair value hedges or cash flow hedges. Our credit exposure, if any, on interest rate swap asset positions is limited to the fair value (net of any collateral pledged to us) and interest payments of all swaps by each counterparty. Conversely, when an interest rate swap is in a liability position exceeding a certain threshold, we may be required to post collateral to the counterparty in an amount determined by the agreements. Collateral levels are monitored and adjusted on a regular basis for changes in interest rate swap values. On July 7, 2023, the Bank entered into various interest rate swap agreements with notional values totaling $101.8 million split evenly between terms of 2.5 and 3.0 years to hedge balance sheet interest rate sensitivity and protect certain of our fixed rate available-for-sale securities against changes in fair value related to changes in the benchmark interest rate. The interest rate swaps involve the receipt of floating rate interest from a counterparty in exchange for us making fixed-rate interest payments over the lives of the agreements, without the exchange of the underlying notional values. The transactions were designated as partial term fair value hedges and structured such that the changes in the fair value of the interest rate swaps are expected to be perfectly effective in offsetting the changes in the fair value of the hedged items attributable to changes in the SOFR OIS swap rate, the designated benchmark interest rate. Because the hedges met the criteria for using the shortcut method, there is no need to periodically reassess effectiveness during the term of the hedges. For fair value designated hedges, the gains or losses on the hedging instruments as well as the offsetting loss or gain on the hedged items, are recognized in current earnings as their fair values change. In addition, we had three interest rate swap agreements on certain loans with our customers, which are scheduled to mature at various dates ranging from June 2031 to July 2032. In December 2023, one interest rate swap, scheduled to mature in October 2037, was terminated as the hedged loan was paid off. The loan interest rate swaps were designated as fair value hedges and allowed us to offer long-term fixed-rate loans to customers without assuming the interest rate risk of a long-term asset. Converting our fixed-rate interest payments to floating-rate interest payments, generally benchmarked to the one-month U.S. dollar SOFR index, protects us against changes in the fair value of our loans associated with fluctuating interest rates. The notional amounts of the interest rate contracts are equal to the notional amounts of the hedged loans. Information on our derivatives follows:
1 Refer to Note 3, Fair Value of Assets and Liabilities, for valuation methodology. The following table presents the carrying amount and associated cumulative basis adjustment related to the application of fair value hedge accounting that is included in the carrying amount of hedged assets as of March 31, 2024 and December 31, 2023.
The following table presents the pretax net gains (losses) recognized in interest income related to our fair value hedges for the years presented.
Our derivative transactions with the counterparty are under an International Swaps and Derivative Association (“ISDA”) master agreement that includes “right of set-off” provisions. “Right of set-off” provisions are legally enforceable rights to offset recognized amounts and there may be an intention to settle such amounts on a net basis. We do not offset such financial instruments for financial reporting purposes. Information on financial instruments that are eligible for offset in the consolidated statements of condition follows:
1 Amounts exclude accrued interest on swaps. For more information on how we account for our interest rate swaps, refer to Note 1 to the Consolidated Financial Statements included in our 2023 Form 10-K filed with the SEC on March 14, 2024.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Basis of Presentation (Policies) |
3 Months Ended |
|---|---|
Mar. 31, 2024 | |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
| Basis of Presentation | The consolidated financial statements include the accounts of Bancorp, a bank holding company, and its wholly-owned bank subsidiary, Bank of Marin, a California state-chartered commercial bank. References to “we,” “our,” “us” mean Bancorp and the Bank that are consolidated for financial reporting purposes. The accompanying unaudited consolidated interim financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and note disclosures normally included in annual financial statements prepared in accordance with U.S. generally accepted accounting principles ("GAAP") have been condensed or omitted pursuant to those rules and regulations. Although we believe that the disclosures are adequate and the information presented is not misleading, we suggest that these interim financial statements be read in conjunction with the annual financial statements and the notes thereto included in our 2023 Annual Report on Form 10-K. In the opinion of management, the unaudited consolidated financial statements reflect all adjustments, which are necessary for a fair presentation of the consolidated financial position, the results of operations, changes in comprehensive income (loss), changes in stockholders’ equity, and cash flows for the periods presented. All material intercompany transactions have been eliminated. The results of these interim periods may not be indicative of the results for the full year or for any other period.
|
| Earnings Per Share | Basic earnings per share (“EPS”) are calculated by dividing net income by the weighted average number of common shares outstanding during each period, excluding unvested restricted stock awards. Diluted EPS are calculated using the weighted average number of potentially dilutive common shares. The number of potentially dilutive common shares included in the quarterly diluted EPS is computed using the average market prices during the three months included in the reporting period under the treasury stock method. The number of potentially dilutive common shares included in year-to-date diluted EPS is a year-to-date weighted average of potentially dilutive common shares included in each quarterly diluted EPS computation. In computing diluted EPS, we exclude anti-dilutive shares such as options whose exercise prices exceed the current common stock price, as they would not reduce EPS under the treasury stock method. We have two forms of outstanding common stock: common stock and unvested restricted stock awards. Holders of unvested restricted stock awards receive non-forfeitable dividends at the same rate as common shareholders and they both share equally in undistributed earnings. Under the two-class method, the difference in EPS is nominal for these participating securities. |
| Recently Adopted and Issued Accounting Standards | Recently Adopted and Issued Accounting Standards Accounting Standards Adopted in 2024 In June 2022, the FASB issued ASU No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. The amendment reduces diversity in practice by clarifying that a separate contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. In addition, this ASU provided amended examples to illustrate that a restriction that is a characteristic of the equity security, which market participants would take into account when pricing them, would be considered in measuring fair value. This ASU also introduced new disclosure requirements. The amendments were effective prospectively for years beginning after December 15, 2023. As discussed in Note 4, Investment Securities, in 2023 we sold our remaining shares of Visa Inc. Class B restricted common stock. As a result of the sale, this update had no impact our financial condition, results of operations or disclosures. In March 2023, the FASB issued ASU No. 2023-01, Leases (Topic 842): Common Control Arrangements. For public companies, the amendment requires entities to amortize leasehold improvements associated with common control lease arrangements over the useful life of the improvements to the common control group, as opposed to the shorter of the remaining lease term and the useful life of the improvements for all other operating leases. The amendments were effective for years beginning after December 15, 2023, and may be adopted either prospectively or retrospectively. We currently do not have common control lease arrangements, and therefore the adoption of the amendments had no impact on our financial condition, results of operations or disclosures. In March 2023, the FASB issued ASU No. 2023-02, Investments—Equity Method and Joint Ventures (Topic 323): Accounting for Investments in Tax Credit Structures Using the Proportional Amortization Method. Under current GAAP, an entity can only elect to apply the proportional amortization method to investments in low-income housing tax credit ("LIHTC") structures. The proportional amortization method results in the cost of the investment being amortized in proportion to the income tax credits and other income tax benefits received, with the amortization of the investment and the income tax credits being presented net in the consolidated statements of income as a component of income tax expense (benefit). The amendments will allow entities to elect to account for all other equity investments made primarily for the purpose of receiving income tax credits to using the proportional amortization method, regardless of the tax credit program through which the investment earns income tax credits, when certain conditions are met. The amendments were effective for fiscal years beginning after December 15, 2023, and may be adopted either on a modified retrospective basis or retrospectively. Other than investments in LIHTC funds, as disclosed in Note 4, Investment Securities, we currently have no other equity investments made primarily for the purpose of receiving income tax credits, and therefore the adoption of this ASU had no impact on our financial condition, results of operations or disclosures. Accounting Standards Not Yet Effective In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments are intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses, enhanced interim disclosure requirements, clarifying circumstances in which an entity can disclose multiple segment measures of profit or loss, providing new segment disclosure requirements for entities with a single reportable segment, and requiring other disclosures. The amendments are effective for annual reporting periods beginning after December 15, 2023 (i.e., 2024 Form 10-K) and interim periods within fiscal years beginning after December 31, 2024, and shall be applied retrospectively to all prior periods presented in the financial statements. Early adoption is permitted. We currently have only one reportable segment and are evaluating the impact the amendments will have on our financial statement disclosures upon adoption. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments require disaggregated information about the effective tax rate reconciliation and additional disclosures on reconciling items and taxes paid that meet a quantitative threshold. The amendments are effective for annual reporting periods beginning after December 15, 2024, and may be adopted either prospectively or retrospectively. Early adoption is permitted. We are currently evaluating the impact of the amendments on our financial statement disclosures upon adoption.
|
| Fair Value Hierarchy and Fair Value Measurement | We group our assets and liabilities that are measured at fair value into three levels within the fair value hierarchy, based on the markets in which the assets and liabilities are traded and the reliability of the assumptions used to determine fair value. These levels are: Level 1: Valuations are based on unadjusted quoted prices in active markets for identical assets or liabilities. Level 2: Valuations are based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuations for which all significant assumptions are observable or can be corroborated by observable market data. Level 3: Valuations are based on unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Values are determined using pricing models and discounted cash flow models and may include significant management judgment and estimation. Transfers between levels of the fair value hierarchy are recognized through our monthly and/or quarterly valuation process in the reporting period during which the event or circumstances that caused the transfer occurred. No such transfers occurred in the years presented. Available-for-sale securities are recorded at fair value on a recurring basis. When available, quoted market prices (Level 1) are used to determine the fair value of available-for-sale securities. Level 1 securities include U.S. Treasury securities. If quoted market prices are not available, we obtain pricing information from a reputable third-party service provider, who may utilize valuation techniques that use current market-based or independently sourced parameters, such as bid/ask prices, dealer-quoted prices, interest rates, benchmark yield curves, prepayment speeds, probability of default, loss severity and credit spreads (Level 2). Level 2 securities include obligations of state and political subdivisions, U.S. agencies or government-sponsored agencies' debt securities, mortgage-backed securities, government agency-issued securities, and corporate bonds.Held-to-maturity securities may be subject to an allowance for credit losses as a result of our evaluation of expected losses due to credit quality factors. Fair value of held-to-maturity securities is determined using the same techniques discussed above for available-for-sale securities.On a recurring basis, derivative financial instruments are recorded at fair value, which is based on the income approach using observable Level 2 market inputs, reflecting market expectations of future interest rates as of the measurement date. Standard valuation techniques are used to calculate the present value of the future expected cash flows assuming an orderly transaction. Valuation adjustments may be made to reflect both our own credit risk and the counterparties’ credit risk in determining the fair value of the derivatives. These unobservable inputs are not considered significant inputs to the fair value measurement overall. Level 2 inputs for the valuations are limited to observable market prices for Secured Overnight Financing Rate ("SOFR") and Overnight Index Swap ("OIS") rates (for the very short term), quoted prices for SOFR futures contracts, observable market prices for SOFR and OIS swap rates, and one-month and three-month SOFR basis spreads at commonly quoted intervals. Mid-market pricing of the inputs is used as a practical expedient in the fair value measurements. We project spot rates at reset days specified by each swap contract to determine future cash flows, then discount to present value using OIS curves as of the measurement date. When the value of any collateral placed with counterparties is less than the interest rate derivative liability, a credit valuation adjustment ("CVA") is applied to reflect the credit risk we pose to counterparties. We have used the spread between the Standard & Poor's BBB rated U.S. Bank Composite rate and SOFR for the closest maturity term corresponding to the duration of the swaps to derive the CVA. Because there is little to no counterparty risk, we did not incorporate credit adjustments from our assessment of the counterparty credit risk in determining fair value. For further discussion on our methodology for valuing our derivative financial instruments, refer to Note 9, Derivative Financial Instruments and Hedging Activities. Certain financial assets may be measured at fair value on a non-recurring basis. These assets are subject to fair value adjustments that result from the application of the lower of cost or fair value accounting or write-downs of individual assets, such as individually analyzed loans that are collateral dependent and other real estate owned ("OREO"). The fair value of loans is based on exit price techniques and obtained from an independent third-party that uses its proprietary valuation model and methodology and may differ from the actual price from a prospective buyer. The discounted cash flow valuation approach reflects key inputs and assumptions that are unobservable, such as loan probability of default, loss given default, prepayment speed, and market discount rates. The fair value of fixed-rate time deposits is estimated by discounting future contractual cash flows using discount rates that reflect the current observable market rates offered for time deposits of similar remaining maturities. The value of off-balance-sheet financial instruments is estimated based on the fee income associated with the commitments, which in the absence of credit exposure, is considered to approximate their settlement value.
|
| Finance, Loan and Lease Receivables, Held-for-investment, Allowance and Nonperforming Loans | Commercial and Industrial Loans - Commercial loans are generally made to established small and mid-sized businesses to provide financing for their growth and working capital needs, equipment purchases and acquisitions. Management examines historical, current, and projected cash flows to determine the ability of the borrower to repay obligations as agreed. Commercial loans are made based primarily on the identified cash flows of the borrower and secondarily on the underlying collateral and guarantor support. The cash flows of borrowers, however, may not occur as expected, and the collateral securing these loans may fluctuate in value. Most commercial and industrial loans are secured by the assets being financed, such as accounts receivable and inventory, and typically include personal guarantees. We target stable businesses with guarantors who provide additional sources of repayment and have proven to be resilient in periods of economic stress. A weakened economy, and resultant decreased consumer and/or business spending, may have an effect on the credit quality of commercial loans. Commercial Real Estate Loans - Commercial real estate loans, which include income producing investment properties and owner-occupied real estate used for business purposes, are subject to underwriting standards and processes similar to commercial loans discussed above. We underwrite these loans to be repaid from cash flow from either the business or investment property and supported by real property collateral. Underwriting standards for commercial real estate loans include, but are not limited to, debt coverage and loan-to-value ratios. Furthermore, a large majority of our loans are guaranteed by the owners of the properties. Conditions in the real estate markets or downturn in the general economy may adversely affect our commercial real estate loans. In the event of a vacancy, we expect guarantors to carry the loans until they find a replacement tenant. The owner's substantial equity investment provides a strong economic incentive to continue to support the commercial real estate projects. As such, we have generally experienced a relatively low level of loss and delinquencies in this portfolio. Construction Loans - Construction loans are generally made to developers and builders to finance construction, renovation and occasionally land acquisitions in anticipation of near-term development. Construction loans include interest reserves that are used for the payment of interest during the development and marketing periods and are capitalized as part of the loan balance. When a construction loan is placed on nonaccrual status before the depletion of the interest reserve, we apply the interest funded by the interest reserve against the loan's principal balance. These loans are underwritten after evaluation of the borrower's financial strength, reputation, prior track record, and independent appraisals. We monitor all construction projects to determine whether they are on schedule, completed as planned and in accordance with the approved construction budgets. Significant events can affect the construction industry, including: the inherent volatility of real estate markets and vulnerability to delays due to weather, change orders, inability to obtain construction permits, labor or material shortages, and price changes. Estimates of construction costs and value associated with the completed project may be inaccurate. Repayment of construction loans is largely dependent on the ultimate success of the project. Consumer Loans - Consumer loans primarily consist of home equity lines of credit, other residential loans, floating homes, and indirect luxury auto loans, along with a small number of installment loans. Our other residential loans include tenancy-in-common fractional interest loans ("TIC") located almost entirely in San Francisco County. We originate consumer loans utilizing credit score information, debt-to-income ratio and loan-to-value ratio analysis. Diversification among consumer loan types, coupled with relatively small loan amounts that are spread across many individual borrowers, mitigates risk. We do not originate sub-prime residential mortgage loans, nor is it our practice to underwrite loans commonly referred to as "Alt-A mortgages," the characteristics of which are reduced documentation, borrowers with low FICO scores or collateral with high loan-to-value ratios. Credit Quality Indicators We use a risk rating system to evaluate asset quality, and to identify and monitor credit risk in individual loans, and in the loan portfolio. Our definitions of “Special Mention” risk graded loans, or worse, are consistent with those used by the Federal Deposit Insurance Corporation ("FDIC"). Our internally assigned grades are as follows: Pass and Watch - Loans to borrowers of acceptable or better credit quality. Borrowers in this category demonstrate fundamentally sound financial positions, repayment capacity, credit history and management expertise. Loans in this category must have an identifiable and stable source of repayment and meet the Bank’s policy regarding debt-service-coverage ratios. These borrowers are capable of sustaining normal economic, market or operational setbacks without significant financial consequences. Negative external industry factors are generally not present. The loan may be secured, unsecured or supported by non-real estate collateral for which the value is more difficult to determine and/or marketability is more uncertain. This category also includes “Watch” loans, where the primary source of repayment has been delayed. “Watch” is intended to be a transitional grade, with either an upgrade or downgrade within a reasonable period. Special Mention - Potential weaknesses that deserve close attention. If left uncorrected, those potential weaknesses may result in deterioration of the payment prospects for the asset. Special Mention assets do not present sufficient risk to warrant adverse classification. Substandard - Inadequately protected by either the current sound worth and paying capacity of the obligor or the collateral pledged, if any. A Substandard asset has well-defined weaknesses that jeopardize the liquidation of the debt. Substandard assets are characterized by the distinct possibility that we will sustain some loss if such weaknesses or deficiencies are not corrected. Well-defined weaknesses include adverse trends or developments of the borrower’s financial condition, managerial weaknesses and/or significant collateral deficiencies. Doubtful - Critical weaknesses that make collection or liquidation in full improbable. There may be specific pending events that work to strengthen the asset; however, the amount or timing of the loss may not be determinable. Pending events generally occur within one year of the asset being classified as Doubtful. Examples include: merger, acquisition, or liquidation; capital injection; guarantee; perfecting liens on additional collateral; and refinancing. Such loans are placed on non-accrual status and usually are collateral-dependent. We regularly review our credits for accuracy of risk grades whenever we receive new information and at each quarterly and year-end reporting period. Borrowers are generally required to submit financial information at regular intervals. Typically, commercial borrowers with lines of credit are required to submit financial information with reporting intervals ranging from monthly to annually depending on credit size, risk and complexity. In addition, investor commercial real estate borrowers with loans exceeding a certain dollar threshold are usually required to submit rent rolls or property income statements annually. We monitor construction loans monthly. We review home equity and other consumer loans based on delinquency. We also review loans graded “Watch” or worse, regardless of loan type, no less than quarterly.
|
Basis of Presentation (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Earnings Per Share Reconciliation | The following table shows: 1) weighted average basic shares, 2) potentially dilutive weighted average common shares related to stock options and unvested restricted stock awards, and 3) weighted average diluted shares. Basic earnings per share (“EPS”) are calculated by dividing net income by the weighted average number of common shares outstanding during each period, excluding unvested restricted stock awards. Diluted EPS are calculated using the weighted average number of potentially dilutive common shares. The number of potentially dilutive common shares included in the quarterly diluted EPS is computed using the average market prices during the three months included in the reporting period under the treasury stock method. The number of potentially dilutive common shares included in year-to-date diluted EPS is a year-to-date weighted average of potentially dilutive common shares included in each quarterly diluted EPS computation. In computing diluted EPS, we exclude anti-dilutive shares such as options whose exercise prices exceed the current common stock price, as they would not reduce EPS under the treasury stock method. We have two forms of outstanding common stock: common stock and unvested restricted stock awards. Holders of unvested restricted stock awards receive non-forfeitable dividends at the same rate as common shareholders and they both share equally in undistributed earnings. Under the two-class method, the difference in EPS is nominal for these participating securities.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value of Assets and Liabilities (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis | The following table summarizes our assets and liabilities that were required to be recorded at fair value on a recurring basis.
1 Other comprehensive income ("OCI") or net income ("NI").
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Fair Value of Financial Instruments | The table below is a summary of fair value estimates for financial instruments as of March 31, 2024 and December 31, 2023, excluding financial instruments recorded at fair value on a recurring basis (summarized in the first table in this note). The carrying amounts in the following table are recorded in the consolidated statements of condition under the indicated captions. Further, we have not disclosed the fair value of financial instruments specifically excluded from disclosure requirements such as bank-owned life insurance policies ("BOLI"), lease obligations and non-maturity deposit liabilities. Additionally, we held shares of Federal Home Loan Bank ("FHLB") of San Francisco stock at cost as of March 31, 2024 and December 31, 2023. There were no impairments or changes resulting from observable price changes in orderly transactions for the identical or similar investments of the same issuer as of March 31, 2024 or December 31, 2023. See further discussion on values within Note 4, Investment Securities.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment Securities (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Held-to-Maturity Amortized Cost and Fair Value | A summary of the amortized cost, fair value and allowance for credit losses related to securities held-to-maturity as of March 31, 2024 and December 31, 2023 is presented below.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Bond Ratings for Held-to-Maturity Securities | The following table summarizes the amortized cost of our portfolio of held-to-maturity securities issued by states and political subdivisions and corporate bonds by Moody's and/or Standard & Poor's bond ratings as of March 31, 2024 and December 31, 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Available-for-Sale Securities Amortized Cost and Fair Value | A summary of the amortized cost, fair value and allowance for credit losses related to securities available-for-sale as of March 31, 2024 and December 31, 2023 is presented below.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Investments Classified by Contractual Maturity Date | The amortized cost and fair value of investment debt securities by contractual maturity at March 31, 2024 and December 31, 2023 are shown below. Expected maturities may differ from contractual maturities if the issuers of the securities have the right to call or prepay obligations with or without call or prepayment penalties.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Financial Instruments Owned and Pledged as Collateral | The reported values of pledged investment securities are shown in the following table.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Unrealized Loss on Investments | Those securities are summarized and classified according to the duration of the loss period in the tables below:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loans and Allowance for Credit Losses on Loans (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Receivables [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Loans by Class | The following table presents the amortized cost of loans by portfolio class as of March 31, 2024 and December 31, 2023.
1 Amortized cost includes net deferred loan origination costs of $2.6 million and $2.7 million at March 31, 2024 and December 31, 2023, respectively. Amounts are also net of unrecognized purchase discounts of $1.9 million and $2.0 million at March 31, 2024 and December 31, 2023, respectively. Amortized cost excludes accrued interest, which totaled $6.3 million and $6.6 million at March 31, 2024 and December 31, 2023, respectively, and is included in in the consolidated statements of condition.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Loans by Risk Grade and Origination Year | The following tables present the loan portfolio by loan portfolio class, origination/renewal year and internal risk rating as of March 31, 2024 and December 31, 2023. The current year vintage table reflects gross charge-offs by loan portfolio class and year of origination. Generally, existing term loans that were re-underwritten are reflected in the table in the year of renewal. Lines of credit that have a conversion feature at the time of origination, such as construction to perm loans, are presented by year of origination.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Loans Outstanding and Aging Analysis | The following table shows the amortized cost of loans by portfolio class, payment aging and non-accrual status as of March 31, 2024 and December 31, 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Collateral Dependent Non-Accrual Loans | The following table presents the amortized cost basis of individually analyzed collateral-dependent loans, which were all on non-accrual status, by portfolio class at March 31, 2024 and December 31, 2023.
1 There were no collateral-dependent residential real estate mortgage loans in process of foreclosure or in substance repossessed at March 31, 2024 and December 31, 2023. The weighted average loan-to-value of real estate secured collateral dependent loans was approximately 82% at March 31, 2024 and 70% at December 31, 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Loan Modifications to Borrowers Experiencing Financial Difficulty | The following table summarizes the amortized cost of loans as of March 31, 2024 that were modified during the three months ended March 31, 2024 by portfolio class and type of modification granted. There were no modifications of loans during the three months ended March 31, 2023 requiring disclosure.
The following table summarizes the financial effect of loan modifications presented in the table above during the three months ended March 31, 2024 by portfolio class.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Allowance for Credit Losses on Financing Receivables | The following table presents the details of the allowance for credit losses on loans segregated by loan portfolio class as of March 31, 2024 and December 31, 2023.
The following table discloses activity in the allowance for credit losses on loans for the periods presented.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Borrowings and Other Obligations (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Debt | The carrying values and weighted average interest rates on borrowings and other obligations as of March 31, 2024 and December 31, 2023 are summarized in the following table.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Information of Cashless Exercise Prices | The table below depicts the total number of shares, amount, and weighted average price withheld for cashless exercises for the periods presented.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Undrawn Loan Commitments and Standby Letters of Credit | The contractual amount of unfunded loan commitments and standby letters of credit not reflected in the consolidated statements of condition are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Operating and Finance Lease Right-of-Use Assets and Lease Liabilities | The following table shows the balances of operating and finance lease right-of-use assets and lease liabilities.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Components of Operating and Finance Lease Cost | The following table shows supplemental disclosures of noncash investing and financing activities for the periods presented.
The following table shows components of operating and finance lease cost.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Operating Lease Liability Maturities | The following table shows the future minimum lease payments, weighted average remaining lease terms, and weighted average discount rates under operating and finance lease arrangements as of March 31, 2024. The discount rates used to calculate the present value of lease liabilities were based on the collateralized FHLB borrowing rates that were commensurate with lease terms and minimum payments on the lease commencement date.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Finance Lease Liability Maturities | The following table shows the future minimum lease payments, weighted average remaining lease terms, and weighted average discount rates under operating and finance lease arrangements as of March 31, 2024. The discount rates used to calculate the present value of lease liabilities were based on the collateralized FHLB borrowing rates that were commensurate with lease terms and minimum payments on the lease commencement date.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Financial Instruments and Hedging Activities (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative Instruments and Hedging Activities Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Derivative Instruments in Statement of Financial Position, Fair Value | Information on our derivatives follows:
1 Refer to Note 3, Fair Value of Assets and Liabilities, for valuation methodology. The following table presents the carrying amount and associated cumulative basis adjustment related to the application of fair value hedge accounting that is included in the carrying amount of hedged assets as of March 31, 2024 and December 31, 2023.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Derivative Instruments, Losses in Statement of Financial Performance | The following table presents the pretax net gains (losses) recognized in interest income related to our fair value hedges for the years presented.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Offsetting Assets and Liabilities | Information on financial instruments that are eligible for offset in the consolidated statements of condition follows:
1 Amounts exclude accrued interest on swaps.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Basis of Presentation (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands |
3 Months Ended | ||
|---|---|---|---|
Mar. 31, 2024 |
Dec. 31, 2023 |
Mar. 31, 2023 |
|
| Earnings Per Share, Basic and Diluted [Abstract] | |||
| Weighted average basic common shares outstanding (in shares) | 16,081 | 16,040 | 15,970 |
| Potentially dilutive common shares related to: | |||
| Stock options (in shares) | 0 | 14 | |
| Unvested restricted stock awards (in shares) | 11 | 15 | |
| Weighted average diluted shares outstanding (in shares) | 16,092 | 16,052 | 15,999 |
| Net income | $ 2,922 | $ 610 | $ 9,440 |
| Basic EPS (in dollars per share) | $ 0.18 | $ 0.04 | $ 0.59 |
| Diluted EPS (in dollars per share) | $ 0.18 | $ 0.04 | $ 0.59 |
| Weighted average anti-dilutive common shares not included in the calculation of diluted EPS (in shares) | 340 | 250 | |
Recently Adopted and Issued Accounting Standards (Details) |
3 Months Ended |
|---|---|
|
Mar. 31, 2024
segment
| |
| Accounting Policies [Abstract] | |
| Number of reportable segments | 1 |
Fair Value of Assets and Liabilities - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - USD ($) $ in Thousands |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | $ 536,365 | $ 552,028 |
| SBA-backed securities | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 17,148 | 19,471 |
| Debentures of government- sponsored agencies | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 66,688 | 66,862 |
| U.S. Treasury securities | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 10,534 | 10,623 |
| Obligations of state and political subdivisions | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 90,343 | 91,882 |
| Corporate bonds | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 10,744 | 10,718 |
| Carrying Value | Assets and liabilities at fair value measured on a recurring basis | Mortgage-backed securities and collateralized mortgage obligations issued by U.S. government-sponsored agencies | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 340,908 | 352,472 |
| Carrying Value | Assets and liabilities at fair value measured on a recurring basis | SBA-backed securities | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 17,148 | 19,471 |
| Carrying Value | Assets and liabilities at fair value measured on a recurring basis | Debentures of government- sponsored agencies | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 66,688 | 66,862 |
| Carrying Value | Assets and liabilities at fair value measured on a recurring basis | U.S. Treasury securities | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 10,534 | 10,623 |
| Carrying Value | Assets and liabilities at fair value measured on a recurring basis | Obligations of state and political subdivisions | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 90,343 | 91,882 |
| Carrying Value | Assets and liabilities at fair value measured on a recurring basis | Corporate bonds | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 10,744 | 10,718 |
| Carrying Value | Assets and liabilities at fair value measured on a recurring basis | Interest rate contracts | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Derivative financial assets (interest rate contracts) | 400 | 287 |
| Derivative financial liabilities (interest rate contracts) | 142 | 1,361 |
| Fair Value | Assets and liabilities at fair value measured on a recurring basis | Mortgage-backed securities and collateralized mortgage obligations issued by U.S. government-sponsored agencies | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 0 | 0 |
| Fair Value | Assets and liabilities at fair value measured on a recurring basis | Mortgage-backed securities and collateralized mortgage obligations issued by U.S. government-sponsored agencies | Significant Other Observable Inputs (Level 2) | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 340,908 | 352,472 |
| Fair Value | Assets and liabilities at fair value measured on a recurring basis | Mortgage-backed securities and collateralized mortgage obligations issued by U.S. government-sponsored agencies | Significant Unobservable Inputs (Level 3) | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 0 | 0 |
| Fair Value | Assets and liabilities at fair value measured on a recurring basis | SBA-backed securities | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 0 | 0 |
| Fair Value | Assets and liabilities at fair value measured on a recurring basis | SBA-backed securities | Significant Other Observable Inputs (Level 2) | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 17,148 | 19,471 |
| Fair Value | Assets and liabilities at fair value measured on a recurring basis | SBA-backed securities | Significant Unobservable Inputs (Level 3) | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 0 | 0 |
| Fair Value | Assets and liabilities at fair value measured on a recurring basis | Debentures of government- sponsored agencies | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 0 | 0 |
| Fair Value | Assets and liabilities at fair value measured on a recurring basis | Debentures of government- sponsored agencies | Significant Other Observable Inputs (Level 2) | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 66,688 | 66,862 |
| Fair Value | Assets and liabilities at fair value measured on a recurring basis | Debentures of government- sponsored agencies | Significant Unobservable Inputs (Level 3) | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 0 | 0 |
| Fair Value | Assets and liabilities at fair value measured on a recurring basis | U.S. Treasury securities | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 10,534 | 10,623 |
| Fair Value | Assets and liabilities at fair value measured on a recurring basis | U.S. Treasury securities | Significant Other Observable Inputs (Level 2) | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 0 | 0 |
| Fair Value | Assets and liabilities at fair value measured on a recurring basis | U.S. Treasury securities | Significant Unobservable Inputs (Level 3) | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 0 | 0 |
| Fair Value | Assets and liabilities at fair value measured on a recurring basis | Obligations of state and political subdivisions | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 0 | 0 |
| Fair Value | Assets and liabilities at fair value measured on a recurring basis | Obligations of state and political subdivisions | Significant Other Observable Inputs (Level 2) | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 90,343 | 91,882 |
| Fair Value | Assets and liabilities at fair value measured on a recurring basis | Obligations of state and political subdivisions | Significant Unobservable Inputs (Level 3) | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 0 | 0 |
| Fair Value | Assets and liabilities at fair value measured on a recurring basis | Corporate bonds | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 0 | 0 |
| Fair Value | Assets and liabilities at fair value measured on a recurring basis | Corporate bonds | Significant Other Observable Inputs (Level 2) | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 10,744 | 10,718 |
| Fair Value | Assets and liabilities at fair value measured on a recurring basis | Corporate bonds | Significant Unobservable Inputs (Level 3) | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available-for-sale securities | 0 | 0 |
| Fair Value | Assets and liabilities at fair value measured on a recurring basis | Interest rate contracts | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Derivative financial assets (interest rate contracts) | 0 | 0 |
| Derivative financial liabilities (interest rate contracts) | 0 | 0 |
| Fair Value | Assets and liabilities at fair value measured on a recurring basis | Interest rate contracts | Significant Other Observable Inputs (Level 2) | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Derivative financial assets (interest rate contracts) | 400 | 287 |
| Derivative financial liabilities (interest rate contracts) | 142 | 1,361 |
| Fair Value | Assets and liabilities at fair value measured on a recurring basis | Interest rate contracts | Significant Unobservable Inputs (Level 3) | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Derivative financial assets (interest rate contracts) | 0 | 0 |
| Derivative financial liabilities (interest rate contracts) | $ 0 | $ 0 |
Fair Value of Assets and Liabilities - Narrative (Details) |
3 Months Ended | ||
|---|---|---|---|
|
Mar. 31, 2024
USD ($)
security
|
Mar. 31, 2023
USD ($)
|
Dec. 31, 2023
security
|
|
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Credit loss expense on held-to-maturity securities | $ | $ 0 | $ 0 | |
| Significant Unobservable Inputs (Level 3) | |||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Number of securities | security | 0 | 0 | |
Fair Value of Assets and Liabilities - Schedule of Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Financial assets (recorded at amortized cost) | ||
| Investment securities held-to-maturity | $ 795,909 | $ 814,830 |
| Level 1 | Carrying Value | ||
| Financial assets (recorded at amortized cost) | ||
| Cash and cash equivalents | 36,308 | 30,453 |
| Level 1 | Fair Value | ||
| Financial assets (recorded at amortized cost) | ||
| Cash and cash equivalents | 36,308 | 30,453 |
| Level 2 | Carrying Value | ||
| Financial assets (recorded at amortized cost) | ||
| Investment securities held-to-maturity | 915,068 | 925,198 |
| Interest receivable | 11,678 | 12,752 |
| Financial liabilities (recorded at amortized cost) | ||
| Time deposits | 267,536 | 251,317 |
| FRBSF short-term borrowings under the BTFP | 0 | 26,000 |
| Interest payable | 3,130 | 2,752 |
| Level 2 | Fair Value | ||
| Financial assets (recorded at amortized cost) | ||
| Investment securities held-to-maturity | 795,909 | 814,830 |
| Interest receivable | 11,678 | 12,752 |
| Financial liabilities (recorded at amortized cost) | ||
| Time deposits | 268,758 | 252,824 |
| FRBSF short-term borrowings under the BTFP | 0 | 25,998 |
| Interest payable | 3,130 | 2,752 |
| Level 3 | Carrying Value | ||
| Financial assets (recorded at amortized cost) | ||
| Loans, net of allowance for credit losses | 2,029,462 | 2,048,548 |
| Level 3 | Fair Value | ||
| Financial assets (recorded at amortized cost) | ||
| Loans, net of allowance for credit losses | $ 1,913,418 | $ 1,939,702 |
Investment Securities - Schedule of Held-to-Maturity Amortized Cost and Fair Value (Details) - USD ($) |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Schedule of Available-for-sale Securities and Held-to-maturity Securities [Line Items] | ||
| Debt securities, held-to-maturity | $ 915,068,000 | $ 925,198,000 |
| Allowance for Credit Losses | 0 | 0 |
| Net Carrying Amount | 915,068,000 | 925,198,000 |
| Held-to-maturity, gross unrealized gains | 4,000 | 75,000 |
| Held-to-maturity, gross unrealized losses | (119,163,000) | (110,443,000) |
| Total | 795,909,000 | 814,830,000 |
| Accrued interest | 2,500,000 | 3,600,000 |
| MBS pass-through securities issued by FHLMC, FNMA and GNMA | ||
| Schedule of Available-for-sale Securities and Held-to-maturity Securities [Line Items] | ||
| Debt securities, held-to-maturity | 300,976,000 | 306,261,000 |
| Allowance for Credit Losses | 0 | 0 |
| Net Carrying Amount | 300,976,000 | 306,261,000 |
| Held-to-maturity, gross unrealized gains | 0 | 0 |
| Held-to-maturity, gross unrealized losses | (48,474,000) | (44,396,000) |
| Total | 252,502,000 | 261,865,000 |
| CMOs issued by FHLMC | ||
| Schedule of Available-for-sale Securities and Held-to-maturity Securities [Line Items] | ||
| Debt securities, held-to-maturity | 224,676,000 | 226,416,000 |
| Allowance for Credit Losses | 0 | 0 |
| Net Carrying Amount | 224,676,000 | 226,416,000 |
| Held-to-maturity, gross unrealized gains | 0 | 28,000 |
| Held-to-maturity, gross unrealized losses | (26,902,000) | (24,869,000) |
| Total | 197,774,000 | 201,575,000 |
| CMOs issued by FNMA | ||
| Schedule of Available-for-sale Securities and Held-to-maturity Securities [Line Items] | ||
| Debt securities, held-to-maturity | 98,951,000 | 101,502,000 |
| Allowance for Credit Losses | 0 | 0 |
| Net Carrying Amount | 98,951,000 | 101,502,000 |
| Held-to-maturity, gross unrealized gains | 0 | 0 |
| Held-to-maturity, gross unrealized losses | (6,009,000) | (4,779,000) |
| Total | 92,942,000 | 96,723,000 |
| CMOs issued by GNMA | ||
| Schedule of Available-for-sale Securities and Held-to-maturity Securities [Line Items] | ||
| Debt securities, held-to-maturity | 50,695,000 | 51,006,000 |
| Allowance for Credit Losses | 0 | 0 |
| Net Carrying Amount | 50,695,000 | 51,006,000 |
| Held-to-maturity, gross unrealized gains | 0 | 0 |
| Held-to-maturity, gross unrealized losses | (5,436,000) | (5,235,000) |
| Total | 45,259,000 | 45,771,000 |
| SBA-backed securities | ||
| Schedule of Available-for-sale Securities and Held-to-maturity Securities [Line Items] | ||
| Debt securities, held-to-maturity | 1,652,000 | 1,853,000 |
| Allowance for Credit Losses | 0 | 0 |
| Net Carrying Amount | 1,652,000 | 1,853,000 |
| Held-to-maturity, gross unrealized gains | 0 | 0 |
| Held-to-maturity, gross unrealized losses | (95,000) | (90,000) |
| Total | 1,557,000 | 1,763,000 |
| Debentures of government- sponsored agencies | ||
| Schedule of Available-for-sale Securities and Held-to-maturity Securities [Line Items] | ||
| Debt securities, held-to-maturity | 146,202,000 | 146,126,000 |
| Allowance for Credit Losses | 0 | 0 |
| Net Carrying Amount | 146,202,000 | 146,126,000 |
| Held-to-maturity, gross unrealized gains | 0 | 0 |
| Held-to-maturity, gross unrealized losses | (22,942,000) | (21,994,000) |
| Total | 123,260,000 | 124,132,000 |
| Obligations of state and political subdivisions | ||
| Schedule of Available-for-sale Securities and Held-to-maturity Securities [Line Items] | ||
| Debt securities, held-to-maturity | 61,916,000 | 62,034,000 |
| Allowance for Credit Losses | 0 | 0 |
| Net Carrying Amount | 61,916,000 | 62,034,000 |
| Held-to-maturity, gross unrealized gains | 4,000 | 47,000 |
| Held-to-maturity, gross unrealized losses | (8,022,000) | (7,884,000) |
| Total | 53,898,000 | 54,197,000 |
| Corporate bonds | ||
| Schedule of Available-for-sale Securities and Held-to-maturity Securities [Line Items] | ||
| Debt securities, held-to-maturity | 30,000,000 | 30,000,000 |
| Allowance for Credit Losses | 0 | 0 |
| Net Carrying Amount | 30,000,000 | 30,000,000 |
| Held-to-maturity, gross unrealized gains | 0 | 0 |
| Held-to-maturity, gross unrealized losses | (1,283,000) | (1,196,000) |
| Total | $ 28,717,000 | $ 28,804,000 |
Investment Securities - Narrative (Details) |
Mar. 31, 2024
USD ($)
security
|
Dec. 31, 2023
USD ($)
security
|
Jul. 07, 2023
USD ($)
|
|---|---|---|---|
| Debt Securities, Available-for-sale [Line Items] | |||
| Held-to-maturity, allowance for credit Loss | $ | $ 0 | $ 0 | |
| Number of investment securities in unrealized loss position | security | 317 | 313 | |
| Number of investment securities in unrealized loss position longer than 12 months | security | 306 | ||
| Number of investment securities in unrealized loss position less than 12 months | security | 11 | ||
| Debt securities, available-for-sale unrealized loss position, allowance for credit loss | $ | $ 0 | $ 0 | |
| Interest rate swap | |||
| Debt Securities, Available-for-sale [Line Items] | |||
| Derivative, notional amount | $ | $ 101,800,000 |
Investment Securities - Schedule of Bond Ratings For Held-to-Maturity Securities (Details) - USD ($) $ in Thousands |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items] | ||
| Debt securities, held-to-maturity | $ 915,068 | $ 925,198 |
| Obligations of state and political subdivisions | ||
| Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items] | ||
| Debt securities, held-to-maturity | 61,916 | 62,034 |
| Corporate bonds | ||
| Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items] | ||
| Debt securities, held-to-maturity | 30,000 | 30,000 |
| Aaa / AAA | Obligations of state and political subdivisions | ||
| Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items] | ||
| Debt securities, held-to-maturity | 42,474 | 42,577 |
| Aaa / AAA | Corporate bonds | ||
| Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items] | ||
| Debt securities, held-to-maturity | 0 | 0 |
| Aa2 / AA | Obligations of state and political subdivisions | ||
| Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items] | ||
| Debt securities, held-to-maturity | 19,442 | 19,457 |
| Aa2 / AA | Corporate bonds | ||
| Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items] | ||
| Debt securities, held-to-maturity | 0 | 0 |
| A2 / A | Obligations of state and political subdivisions | ||
| Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items] | ||
| Debt securities, held-to-maturity | 0 | 0 |
| A2 / A | Corporate bonds | ||
| Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items] | ||
| Debt securities, held-to-maturity | $ 30,000 | $ 30,000 |
Investment Securities - Schedule of Available-for-Sale Securities Amortized Cost and Fair Value (Details) - USD ($) |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Debt Securities, Available-for-sale [Line Items] | ||
| Available-for-sale, amortized cost | $ 602,384,000 | $ 613,479,000 |
| Available-for-sale, gross unrealized gains | 2,000 | 3,000 |
| Available-for-sale, gross unrealized losses | (66,021,000) | (61,454,000) |
| Allowance for Credit Losses | 0 | 0 |
| Fair Value | $ 536,365,000 | $ 552,028,000 |
| Debt securities, available-for-sale, accrued interest, after allowance for credit loss, statement of financial position [Extensible Enumeration] | Interest receivable and other assets | Interest receivable and other assets |
| Accrued interest | $ 2,300,000 | $ 2,300,000 |
| MBS pass-through securities issued by FHLMC, FNMA and GNMA | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Available-for-sale, amortized cost | 79,460,000 | 81,937,000 |
| Available-for-sale, gross unrealized gains | 2,000 | 2,000 |
| Available-for-sale, gross unrealized losses | (10,073,000) | (9,516,000) |
| Allowance for Credit Losses | 0 | 0 |
| Fair Value | 69,389,000 | 72,423,000 |
| CMOs issued by FHLMC | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Available-for-sale, amortized cost | 261,797,000 | 266,407,000 |
| Available-for-sale, gross unrealized gains | 0 | 0 |
| Available-for-sale, gross unrealized losses | (26,837,000) | (24,758,000) |
| Allowance for Credit Losses | 0 | 0 |
| Fair Value | 234,960,000 | 241,649,000 |
| CMOs issued by FNMA | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Available-for-sale, amortized cost | 23,099,000 | 23,987,000 |
| Available-for-sale, gross unrealized gains | 0 | 0 |
| Available-for-sale, gross unrealized losses | (2,835,000) | (2,715,000) |
| Allowance for Credit Losses | 0 | 0 |
| Fair Value | 20,264,000 | 21,272,000 |
| CMOs issued by GNMA | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Available-for-sale, amortized cost | 19,486,000 | 20,006,000 |
| Available-for-sale, gross unrealized gains | 0 | 0 |
| Available-for-sale, gross unrealized losses | (3,191,000) | (2,878,000) |
| Allowance for Credit Losses | 0 | 0 |
| Fair Value | 16,295,000 | 17,128,000 |
| SBA-backed securities | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Available-for-sale, amortized cost | 18,805,000 | 21,126,000 |
| Available-for-sale, gross unrealized gains | 0 | 0 |
| Available-for-sale, gross unrealized losses | (1,657,000) | (1,655,000) |
| Allowance for Credit Losses | 0 | 0 |
| Fair Value | 17,148,000 | 19,471,000 |
| Debentures of government- sponsored agencies | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Available-for-sale, amortized cost | 73,906,000 | 73,899,000 |
| Available-for-sale, gross unrealized gains | 0 | 0 |
| Available-for-sale, gross unrealized losses | (7,218,000) | (7,037,000) |
| Allowance for Credit Losses | 0 | 0 |
| Fair Value | 66,688,000 | 66,862,000 |
| U.S. Treasury securities | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Available-for-sale, amortized cost | 11,928,000 | 11,923,000 |
| Available-for-sale, gross unrealized gains | 0 | 0 |
| Available-for-sale, gross unrealized losses | (1,394,000) | (1,300,000) |
| Allowance for Credit Losses | 0 | |
| Fair Value | 10,534,000 | 10,623,000 |
| Obligations of state and political subdivisions | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Available-for-sale, amortized cost | 101,911,000 | 102,202,000 |
| Available-for-sale, gross unrealized gains | 0 | 1,000 |
| Available-for-sale, gross unrealized losses | (11,568,000) | (10,321,000) |
| Allowance for Credit Losses | 0 | 0 |
| Fair Value | 90,343,000 | 91,882,000 |
| Corporate bonds | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Available-for-sale, amortized cost | 11,992,000 | 11,992,000 |
| Available-for-sale, gross unrealized gains | 0 | 0 |
| Available-for-sale, gross unrealized losses | (1,248,000) | (1,274,000) |
| Allowance for Credit Losses | 0 | 0 |
| Fair Value | $ 10,744,000 | $ 10,718,000 |
Investment Securities - Schedule of Investments Classified by Contractual Maturity Date (Details) - USD ($) $ in Thousands |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Held-to-maturity Securities, Amortized Cost | ||
| Within one year | $ 15,000 | $ 0 |
| After one but within five years | 72,200 | 87,887 |
| After five years through ten years | 304,877 | 304,976 |
| After ten years | 522,991 | 532,335 |
| Total | 915,068 | 925,198 |
| Held-to-maturity Securities, Fair Value | ||
| Within one year | 14,615 | 0 |
| After one but within five years | 69,109 | 84,541 |
| After five years through ten years | 259,599 | 261,654 |
| After ten years | 452,586 | 468,635 |
| Total | 795,909 | 814,830 |
| Available-for-sale Securities, Amortized Cost | ||
| Within one year | 4,181 | 101 |
| After one but within five years | 249,923 | 226,669 |
| After five years through ten years | 62,426 | 95,552 |
| After ten years | 285,854 | 291,157 |
| Total | 602,384 | 613,479 |
| Available-for-sale Securities, Fair Value | ||
| Within one year | 4,076 | 100 |
| After one but within five years | 228,662 | 208,444 |
| After five years through ten years | 54,421 | 85,447 |
| After ten years | 249,206 | 258,037 |
| Total | $ 536,365 | $ 552,028 |
Investment Securities - Schedule of Financial Instruments Owned and Pledged as Collateral (Details) - USD ($) $ in Thousands |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Available-for-sale securities pledged as collateral | $ 927,555 | $ 938,959 |
| State of California | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Available-for-sale securities pledged as collateral | 284,042 | 288,664 |
| Public deposits | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Available-for-sale securities pledged as collateral | 282,826 | 287,436 |
| Trust deposits | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Available-for-sale securities pledged as collateral | 659 | 666 |
| Internal checking account | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Available-for-sale securities pledged as collateral | 557 | 562 |
| Bankruptcy trustee deposits | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Available-for-sale securities pledged as collateral | 1,003 | 1,151 |
| FHLB Securities Backed Credit Program | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Available-for-sale securities pledged as collateral | 296,614 | 383,484 |
| FRBSF short-term borrowings under the BTFP | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Available-for-sale securities pledged as collateral | 0 | 265,660 |
| Federal Reserve Discount Window | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Available-for-sale securities pledged as collateral | $ 345,896 | $ 0 |
Investment Securities - Schedule of Unrealized Loss on Investments (Details) - USD ($) $ in Thousands |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Debt Securities, Held-to-maturity, Fair Value | ||
| Less than 12 continuous months | $ 70,814 | $ 62,124 |
| Greater than or equal to 12 continuous months | 722,027 | 738,690 |
| Total securities in a loss position | 792,841 | 800,814 |
| Debt Securities, Held-to-maturity, Unrealized Loss | ||
| Less than 12 continuous months | (1,518) | (676) |
| Greater than or equal to 12 continuous months | (117,645) | (109,767) |
| Held-to-maturity, gross unrealized losses | (119,163) | (110,443) |
| Debt Securities, Available-For-Sale, Fair Value | ||
| Available-for-sale, less than 12 continuous months, fair value | 1,518 | 1,901 |
| Available-for-sale, greater than 12 continuous months, fair value | 534,613 | 549,289 |
| Available-for-sale, total securities in a loss position, fair value | 536,131 | 551,190 |
| Debt Securities, Available-for-sale, Unrealized Loss | ||
| Available-for-sale, less than 12 continuous months, unrealized loss | (6) | (8) |
| Available-for-sale, greater than 12 continuous months, unrealized loss | (66,015) | (61,446) |
| Available-for-sale, total securities in a loss position, unrealized loss | (66,021) | (61,454) |
| Marketable Securities, Fair Value | ||
| Marketable securities, less than 12 continuous months, fair value | 72,332 | 64,025 |
| Marketable securities, greater than 12 continuous months, fair value | 1,256,640 | 1,287,979 |
| Marketable securities, total securities in a loss position, fair value | 1,328,972 | 1,352,004 |
| Marketable Securities, Continuous Unrealized Loss | ||
| Marketable securities, less than 12 continuous months, unrealized loss | (1,524) | (684) |
| Marketable securities, greater than 12 continuous months, unrealized loss | (183,660) | (171,213) |
| Marketable securities, total securities in a loss position, unrealized loss | (185,184) | (171,897) |
| MBS pass-through securities issued by FHLMC, FNMA and GNMA | ||
| Debt Securities, Held-to-maturity, Fair Value | ||
| Less than 12 continuous months | 0 | 0 |
| Greater than or equal to 12 continuous months | 252,501 | 261,865 |
| Total securities in a loss position | 252,501 | 261,865 |
| Debt Securities, Held-to-maturity, Unrealized Loss | ||
| Less than 12 continuous months | 0 | 0 |
| Greater than or equal to 12 continuous months | (48,474) | (44,396) |
| Held-to-maturity, gross unrealized losses | (48,474) | (44,396) |
| Debt Securities, Available-For-Sale, Fair Value | ||
| Available-for-sale, less than 12 continuous months, fair value | 3 | 0 |
| Available-for-sale, greater than 12 continuous months, fair value | 69,152 | 72,146 |
| Available-for-sale, total securities in a loss position, fair value | 69,155 | 72,146 |
| Debt Securities, Available-for-sale, Unrealized Loss | ||
| Available-for-sale, less than 12 continuous months, unrealized loss | 0 | 0 |
| Available-for-sale, greater than 12 continuous months, unrealized loss | (10,073) | (9,516) |
| Available-for-sale, total securities in a loss position, unrealized loss | (10,073) | (9,516) |
| CMOs issued by FHLMC | ||
| Debt Securities, Held-to-maturity, Fair Value | ||
| Less than 12 continuous months | 12,455 | 8,662 |
| Greater than or equal to 12 continuous months | 185,319 | 188,657 |
| Total securities in a loss position | 197,774 | 197,319 |
| Debt Securities, Held-to-maturity, Unrealized Loss | ||
| Less than 12 continuous months | (68) | (21) |
| Greater than or equal to 12 continuous months | (26,834) | (24,848) |
| Held-to-maturity, gross unrealized losses | (26,902) | (24,869) |
| Debt Securities, Available-For-Sale, Fair Value | ||
| Available-for-sale, less than 12 continuous months, fair value | 958 | 1,235 |
| Available-for-sale, greater than 12 continuous months, fair value | 234,002 | 240,414 |
| Available-for-sale, total securities in a loss position, fair value | 234,960 | 241,649 |
| Debt Securities, Available-for-sale, Unrealized Loss | ||
| Available-for-sale, less than 12 continuous months, unrealized loss | (4) | (7) |
| Available-for-sale, greater than 12 continuous months, unrealized loss | (26,833) | (24,751) |
| Available-for-sale, total securities in a loss position, unrealized loss | (26,837) | (24,758) |
| CMOs issued by FNMA | ||
| Debt Securities, Held-to-maturity, Fair Value | ||
| Less than 12 continuous months | 40,962 | 42,474 |
| Greater than or equal to 12 continuous months | 51,980 | 54,249 |
| Total securities in a loss position | 92,942 | 96,723 |
| Debt Securities, Held-to-maturity, Unrealized Loss | ||
| Less than 12 continuous months | (1,054) | (411) |
| Greater than or equal to 12 continuous months | (4,955) | (4,368) |
| Held-to-maturity, gross unrealized losses | (6,009) | (4,779) |
| Debt Securities, Available-For-Sale, Fair Value | ||
| Available-for-sale, less than 12 continuous months, fair value | 0 | 0 |
| Available-for-sale, greater than 12 continuous months, fair value | 20,264 | 21,272 |
| Available-for-sale, total securities in a loss position, fair value | 20,264 | 21,272 |
| Debt Securities, Available-for-sale, Unrealized Loss | ||
| Available-for-sale, less than 12 continuous months, unrealized loss | 0 | 0 |
| Available-for-sale, greater than 12 continuous months, unrealized loss | (2,835) | (2,715) |
| Available-for-sale, total securities in a loss position, unrealized loss | (2,835) | (2,715) |
| CMOs issued by GNMA | ||
| Debt Securities, Held-to-maturity, Fair Value | ||
| Less than 12 continuous months | 10,808 | 10,988 |
| Greater than or equal to 12 continuous months | 34,452 | 34,783 |
| Total securities in a loss position | 45,260 | 45,771 |
| Debt Securities, Held-to-maturity, Unrealized Loss | ||
| Less than 12 continuous months | (350) | (244) |
| Greater than or equal to 12 continuous months | (5,086) | (4,991) |
| Held-to-maturity, gross unrealized losses | (5,436) | (5,235) |
| Debt Securities, Available-For-Sale, Fair Value | ||
| Available-for-sale, less than 12 continuous months, fair value | 0 | 0 |
| Available-for-sale, greater than 12 continuous months, fair value | 16,295 | 17,128 |
| Available-for-sale, total securities in a loss position, fair value | 16,295 | 17,128 |
| Debt Securities, Available-for-sale, Unrealized Loss | ||
| Available-for-sale, less than 12 continuous months, unrealized loss | 0 | 0 |
| Available-for-sale, greater than 12 continuous months, unrealized loss | (3,191) | (2,878) |
| Available-for-sale, total securities in a loss position, unrealized loss | (3,191) | (2,878) |
| SBA-backed securities | ||
| Debt Securities, Held-to-maturity, Fair Value | ||
| Less than 12 continuous months | 0 | 0 |
| Greater than or equal to 12 continuous months | 1,556 | 1,763 |
| Total securities in a loss position | 1,556 | 1,763 |
| Debt Securities, Held-to-maturity, Unrealized Loss | ||
| Less than 12 continuous months | 0 | 0 |
| Greater than or equal to 12 continuous months | (95) | (90) |
| Held-to-maturity, gross unrealized losses | (95) | (90) |
| Debt Securities, Available-For-Sale, Fair Value | ||
| Available-for-sale, less than 12 continuous months, fair value | 0 | 0 |
| Available-for-sale, greater than 12 continuous months, fair value | 17,148 | 19,471 |
| Available-for-sale, total securities in a loss position, fair value | 17,148 | 19,471 |
| Debt Securities, Available-for-sale, Unrealized Loss | ||
| Available-for-sale, less than 12 continuous months, unrealized loss | 0 | 0 |
| Available-for-sale, greater than 12 continuous months, unrealized loss | (1,657) | (1,655) |
| Available-for-sale, total securities in a loss position, unrealized loss | (1,657) | (1,655) |
| Debentures of government- sponsored agencies | ||
| Debt Securities, Held-to-maturity, Fair Value | ||
| Less than 12 continuous months | 0 | 0 |
| Greater than or equal to 12 continuous months | 123,260 | 124,132 |
| Total securities in a loss position | 123,260 | 124,132 |
| Debt Securities, Held-to-maturity, Unrealized Loss | ||
| Less than 12 continuous months | 0 | 0 |
| Greater than or equal to 12 continuous months | (22,942) | (21,994) |
| Held-to-maturity, gross unrealized losses | (22,942) | (21,994) |
| Debt Securities, Available-For-Sale, Fair Value | ||
| Available-for-sale, less than 12 continuous months, fair value | 0 | 0 |
| Available-for-sale, greater than 12 continuous months, fair value | 66,688 | 66,862 |
| Available-for-sale, total securities in a loss position, fair value | 66,688 | 66,862 |
| Debt Securities, Available-for-sale, Unrealized Loss | ||
| Available-for-sale, less than 12 continuous months, unrealized loss | 0 | 0 |
| Available-for-sale, greater than 12 continuous months, unrealized loss | (7,218) | (7,037) |
| Available-for-sale, total securities in a loss position, unrealized loss | (7,218) | (7,037) |
| U.S. Treasury securities | ||
| Debt Securities, Available-For-Sale, Fair Value | ||
| Available-for-sale, less than 12 continuous months, fair value | 0 | 0 |
| Available-for-sale, greater than 12 continuous months, fair value | 10,534 | 10,623 |
| Available-for-sale, total securities in a loss position, fair value | 10,534 | 10,623 |
| Debt Securities, Available-for-sale, Unrealized Loss | ||
| Available-for-sale, less than 12 continuous months, unrealized loss | 0 | 0 |
| Available-for-sale, greater than 12 continuous months, unrealized loss | (1,394) | (1,300) |
| Available-for-sale, total securities in a loss position, unrealized loss | (1,394) | (1,300) |
| Obligations of state and political subdivisions | ||
| Debt Securities, Held-to-maturity, Fair Value | ||
| Less than 12 continuous months | 6,589 | 0 |
| Greater than or equal to 12 continuous months | 44,242 | 44,437 |
| Total securities in a loss position | 50,831 | 44,437 |
| Debt Securities, Held-to-maturity, Unrealized Loss | ||
| Less than 12 continuous months | (46) | 0 |
| Greater than or equal to 12 continuous months | (7,976) | (7,884) |
| Held-to-maturity, gross unrealized losses | (8,022) | (7,884) |
| Debt Securities, Available-For-Sale, Fair Value | ||
| Available-for-sale, less than 12 continuous months, fair value | 557 | 666 |
| Available-for-sale, greater than 12 continuous months, fair value | 89,786 | 90,655 |
| Available-for-sale, total securities in a loss position, fair value | 90,343 | 91,321 |
| Debt Securities, Available-for-sale, Unrealized Loss | ||
| Available-for-sale, less than 12 continuous months, unrealized loss | (2) | (1) |
| Available-for-sale, greater than 12 continuous months, unrealized loss | (11,566) | (10,320) |
| Available-for-sale, total securities in a loss position, unrealized loss | (11,568) | (10,321) |
| Corporate bonds | ||
| Debt Securities, Held-to-maturity, Fair Value | ||
| Less than 12 continuous months | 0 | 0 |
| Greater than or equal to 12 continuous months | 28,717 | 28,804 |
| Total securities in a loss position | 28,717 | 28,804 |
| Debt Securities, Held-to-maturity, Unrealized Loss | ||
| Less than 12 continuous months | 0 | 0 |
| Greater than or equal to 12 continuous months | (1,283) | (1,196) |
| Held-to-maturity, gross unrealized losses | (1,283) | (1,196) |
| Debt Securities, Available-For-Sale, Fair Value | ||
| Available-for-sale, less than 12 continuous months, fair value | 0 | 0 |
| Available-for-sale, greater than 12 continuous months, fair value | 10,744 | 10,718 |
| Available-for-sale, total securities in a loss position, fair value | 10,744 | 10,718 |
| Debt Securities, Available-for-sale, Unrealized Loss | ||
| Available-for-sale, less than 12 continuous months, unrealized loss | 0 | 0 |
| Available-for-sale, greater than 12 continuous months, unrealized loss | (1,248) | (1,274) |
| Available-for-sale, total securities in a loss position, unrealized loss | $ (1,248) | $ (1,274) |
Investment Securities - Non-Marketable Securities Included in Other Assets (Details) - USD ($) |
3 Months Ended | |||
|---|---|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
Apr. 25, 2024 |
Dec. 31, 2023 |
|
| Schedule of Equity Method Investments [Line Items] | ||||
| Federal home loan bank stock, par value (in usd per share) | $ 100 | |||
| Investments in low income housing tax credit funds | $ 1,900,000 | $ 2,000,000 | ||
| Low income housing tax credits and other tax benefits | 133,000 | |||
| Low income housing amortization expense | 111,000 | |||
| Unfunded commitments for low income housing tax credit funds | 343,000 | |||
| Impairment losses | 0 | $ 0 | ||
| Subsequent event | ||||
| Schedule of Equity Method Investments [Line Items] | ||||
| Federal home loan bank, dividend rate percentage | 8.25% | |||
| Asset derivatives | ||||
| Schedule of Equity Method Investments [Line Items] | ||||
| Federal home loan bank stock | $ 16,700,000 | $ 16,700,000 | ||
Loans and Allowance for Credit Losses on Loans - Schedule of Loans by Class (Details) - USD ($) $ in Thousands |
Mar. 31, 2024 |
Dec. 31, 2023 |
Mar. 31, 2023 |
Dec. 31, 2022 |
|---|---|---|---|---|
| Financing Receivable, Allowance for Credit Loss [Line Items] | ||||
| Loans, at amortized cost | $ 2,054,963 | $ 2,073,720 | ||
| Allowance for credit losses on loans | (25,501) | (25,172) | $ (23,330) | $ (22,983) |
| Loans, net of allowance for credit losses on loans | 2,029,462 | 2,048,548 | ||
| Net deferred loan origination costs | 2,600 | 2,700 | ||
| Unrecognized purchase discounts on non-PCI loans | 1,900 | 2,000 | ||
| Financing receivable, accrued interest, net | $ 6,300 | $ 6,600 | ||
| Financing Receivable, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration] | Interest receivable and other assets | Interest receivable and other assets | ||
| Commercial loans | Commercial and industrial | ||||
| Financing Receivable, Allowance for Credit Loss [Line Items] | ||||
| Loans, at amortized cost | $ 150,896 | $ 153,750 | ||
| Allowance for credit losses on loans | (1,727) | (1,712) | (1,941) | (1,794) |
| Commercial real estate loans | Commercial owner-occupied | ||||
| Financing Receivable, Allowance for Credit Loss [Line Items] | ||||
| Loans, at amortized cost | 328,560 | 333,181 | ||
| Allowance for credit losses on loans | (2,500) | (2,476) | (2,640) | (2,487) |
| Commercial real estate loans | Commercial non-owner occupied | ||||
| Financing Receivable, Allowance for Credit Loss [Line Items] | ||||
| Loans, at amortized cost | 1,236,633 | 1,219,385 | ||
| Allowance for credit losses on loans | (15,704) | (14,933) | (12,701) | (12,676) |
| Commercial real estate loans | Construction | ||||
| Financing Receivable, Allowance for Credit Loss [Line Items] | ||||
| Loans, at amortized cost | 71,494 | 99,164 | ||
| Allowance for credit losses on loans | (1,282) | (1,832) | (2,019) | (1,937) |
| Residential loans | Home equity | ||||
| Financing Receivable, Allowance for Credit Loss [Line Items] | ||||
| Loans, at amortized cost | 86,794 | 82,087 | ||
| Allowance for credit losses on loans | (627) | (552) | (538) | (558) |
| Residential loans | Other residential | ||||
| Financing Receivable, Allowance for Credit Loss [Line Items] | ||||
| Loans, at amortized cost | 113,479 | 118,508 | ||
| Allowance for credit losses on loans | (692) | (653) | (577) | (595) |
| Consumer loans | Installment and other consumer loans | ||||
| Financing Receivable, Allowance for Credit Loss [Line Items] | ||||
| Loans, at amortized cost | 67,107 | 67,645 | ||
| Allowance for credit losses on loans | $ (920) | $ (976) | $ (882) | $ (868) |
Loans and Allowance for Credit Losses on Loans - Schedule of Loans by Risk Grade and Origination Year (Details) - USD ($) $ in Thousands |
3 Months Ended | ||
|---|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
Dec. 31, 2023 |
|
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | $ 43,724 | $ 183,397 | |
| Financing receivable, originated, year two | 173,241 | 291,859 | |
| Financing receivable, originated, year three | 282,725 | 320,078 | |
| Financing receivable, originated, year four | 297,858 | 264,689 | |
| Financing receivable, originated, year five | 262,668 | 239,856 | |
| Prior | 824,227 | 610,122 | |
| Revolving Loans Amortized Cost | 170,520 | 163,719 | |
| Total | 2,054,963 | 2,073,720 | |
| Gross current period charge-offs, originated, year one | 0 | ||
| Gross current period charge-offs, originated, year two | (14) | ||
| Gross current period charge-offs, originated, year three | 0 | ||
| Gross current period charge-offs, originated, year four | (3) | ||
| Gross current period charge-offs, originated, year five | 0 | ||
| Gross current period charge-offs, originated, prior | 0 | ||
| Gross current period charge-offs, originated, revolving loans amortized cost | (4) | ||
| Gross current period charge-offs, originated, total | (21) | $ (14) | |
| Pass and Watch | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 43,364 | 168,498 | |
| Financing receivable, originated, year two | 159,169 | 282,068 | |
| Financing receivable, originated, year three | 277,748 | 292,740 | |
| Financing receivable, originated, year four | 271,743 | 252,093 | |
| Financing receivable, originated, year five | 250,156 | 222,217 | |
| Prior | 736,094 | 534,401 | |
| Revolving Loans Amortized Cost | 160,942 | 154,208 | |
| Total | 1,899,216 | 1,906,225 | |
| Special Mention | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 0 | 14,021 | |
| Financing receivable, originated, year two | 13,200 | 7,288 | |
| Financing receivable, originated, year three | 2,776 | 25,134 | |
| Financing receivable, originated, year four | 23,800 | 12,596 | |
| Financing receivable, originated, year five | 12,512 | 16,328 | |
| Prior | 47,216 | 50,504 | |
| Revolving Loans Amortized Cost | 1,443 | 9,300 | |
| Total | 100,947 | 135,171 | |
| Substandard | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 360 | 878 | |
| Financing receivable, originated, year two | 872 | 2,503 | |
| Financing receivable, originated, year three | 2,201 | 2,204 | |
| Financing receivable, originated, year four | 2,315 | 0 | |
| Financing receivable, originated, year five | 0 | 1,311 | |
| Prior | 40,917 | 25,217 | |
| Revolving Loans Amortized Cost | 8,135 | 211 | |
| Total | 54,800 | 32,324 | |
| Commercial loans | Commercial and industrial | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 2,650 | 25,615 | |
| Financing receivable, originated, year two | 23,105 | 9,187 | |
| Financing receivable, originated, year three | 9,107 | 2,970 | |
| Financing receivable, originated, year four | 2,726 | 3,718 | |
| Financing receivable, originated, year five | 3,474 | 16,773 | |
| Prior | 36,195 | 23,701 | |
| Revolving Loans Amortized Cost | 73,639 | 71,786 | |
| Total | 150,896 | 153,750 | |
| Gross current period charge-offs, originated, year one | 0 | ||
| Gross current period charge-offs, originated, year two | 0 | ||
| Gross current period charge-offs, originated, year three | 0 | ||
| Gross current period charge-offs, originated, year four | 0 | ||
| Gross current period charge-offs, originated, year five | 0 | ||
| Gross current period charge-offs, originated, prior | 0 | ||
| Gross current period charge-offs, originated, revolving loans amortized cost | (4) | ||
| Gross current period charge-offs, originated, total | (4) | (3) | |
| Commercial loans | Commercial and industrial | Pass and Watch | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 2,650 | 25,615 | |
| Financing receivable, originated, year two | 23,105 | 9,187 | |
| Financing receivable, originated, year three | 9,107 | 2,970 | |
| Financing receivable, originated, year four | 2,726 | 3,718 | |
| Financing receivable, originated, year five | 3,474 | 15,128 | |
| Prior | 33,698 | 21,004 | |
| Revolving Loans Amortized Cost | 64,683 | 62,486 | |
| Total | 139,443 | 140,108 | |
| Commercial loans | Commercial and industrial | Special Mention | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 0 | 0 | |
| Financing receivable, originated, year two | 0 | 0 | |
| Financing receivable, originated, year three | 0 | 0 | |
| Financing receivable, originated, year four | 0 | 0 | |
| Financing receivable, originated, year five | 0 | 334 | |
| Prior | 306 | 0 | |
| Revolving Loans Amortized Cost | 1,443 | 9,300 | |
| Total | 1,749 | 9,634 | |
| Commercial loans | Commercial and industrial | Substandard | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 0 | 0 | |
| Financing receivable, originated, year two | 0 | 0 | |
| Financing receivable, originated, year three | 0 | 0 | |
| Financing receivable, originated, year four | 0 | 0 | |
| Financing receivable, originated, year five | 0 | 1,311 | |
| Prior | 2,191 | 2,697 | |
| Revolving Loans Amortized Cost | 7,513 | 0 | |
| Total | 9,704 | 4,008 | |
| Commercial real estate loans | Commercial owner-occupied | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 3,187 | 14,559 | |
| Financing receivable, originated, year two | 14,439 | 48,537 | |
| Financing receivable, originated, year three | 48,149 | 65,523 | |
| Financing receivable, originated, year four | 64,997 | 38,528 | |
| Financing receivable, originated, year five | 36,978 | 41,280 | |
| Prior | 160,805 | 124,698 | |
| Revolving Loans Amortized Cost | 5 | 56 | |
| Total | 328,560 | 333,181 | |
| Gross current period charge-offs, originated, total | 0 | 0 | |
| Commercial real estate loans | Commercial owner-occupied | Pass and Watch | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 3,187 | 13,128 | |
| Financing receivable, originated, year two | 14,053 | 41,808 | |
| Financing receivable, originated, year three | 45,948 | 49,887 | |
| Financing receivable, originated, year four | 49,506 | 37,708 | |
| Financing receivable, originated, year five | 36,162 | 40,994 | |
| Prior | 148,036 | 114,018 | |
| Revolving Loans Amortized Cost | 5 | 56 | |
| Total | 296,897 | 297,599 | |
| Commercial real estate loans | Commercial owner-occupied | Special Mention | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 0 | 1,431 | |
| Financing receivable, originated, year two | 386 | 4,498 | |
| Financing receivable, originated, year three | 0 | 15,636 | |
| Financing receivable, originated, year four | 15,491 | 820 | |
| Financing receivable, originated, year five | 816 | 286 | |
| Prior | 10,113 | 8,902 | |
| Revolving Loans Amortized Cost | 0 | 0 | |
| Total | 26,806 | 31,573 | |
| Commercial real estate loans | Commercial owner-occupied | Substandard | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 0 | 0 | |
| Financing receivable, originated, year two | 0 | 2,231 | |
| Financing receivable, originated, year three | 2,201 | 0 | |
| Financing receivable, originated, year four | 0 | 0 | |
| Financing receivable, originated, year five | 0 | 0 | |
| Prior | 2,656 | 1,778 | |
| Revolving Loans Amortized Cost | 0 | 0 | |
| Total | 4,857 | 4,009 | |
| Commercial real estate loans | Commercial non-owner occupied | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 20,511 | 77,596 | |
| Financing receivable, originated, year two | 77,338 | 175,090 | |
| Financing receivable, originated, year three | 173,896 | 208,042 | |
| Financing receivable, originated, year four | 206,570 | 162,607 | |
| Financing receivable, originated, year five | 172,955 | 155,568 | |
| Prior | 575,261 | 430,650 | |
| Revolving Loans Amortized Cost | 10,102 | 9,832 | |
| Total | 1,236,633 | 1,219,385 | |
| Gross current period charge-offs, originated, total | 0 | 0 | |
| Commercial real estate loans | Commercial non-owner occupied | Pass and Watch | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 20,233 | 76,718 | |
| Financing receivable, originated, year two | 76,466 | 172,028 | |
| Financing receivable, originated, year three | 171,120 | 196,340 | |
| Financing receivable, originated, year four | 196,087 | 150,831 | |
| Financing receivable, originated, year five | 161,259 | 139,860 | |
| Prior | 502,571 | 368,675 | |
| Revolving Loans Amortized Cost | 10,102 | 9,832 | |
| Total | 1,137,838 | 1,114,284 | |
| Commercial real estate loans | Commercial non-owner occupied | Special Mention | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 0 | 0 | |
| Financing receivable, originated, year two | 0 | 2,790 | |
| Financing receivable, originated, year three | 2,776 | 9,498 | |
| Financing receivable, originated, year four | 8,309 | 11,776 | |
| Financing receivable, originated, year five | 11,696 | 15,708 | |
| Prior | 36,797 | 41,602 | |
| Revolving Loans Amortized Cost | 0 | 0 | |
| Total | 59,578 | 81,374 | |
| Commercial real estate loans | Commercial non-owner occupied | Substandard | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 278 | 878 | |
| Financing receivable, originated, year two | 872 | 272 | |
| Financing receivable, originated, year three | 0 | 2,204 | |
| Financing receivable, originated, year four | 2,174 | 0 | |
| Financing receivable, originated, year five | 0 | 0 | |
| Prior | 35,893 | 20,373 | |
| Revolving Loans Amortized Cost | 0 | 0 | |
| Total | 39,217 | 23,727 | |
| Commercial real estate loans | Construction | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 13,915 | 25,728 | |
| Financing receivable, originated, year two | 20,475 | 24,403 | |
| Financing receivable, originated, year three | 17,794 | 19,521 | |
| Financing receivable, originated, year four | 0 | 29,512 | |
| Financing receivable, originated, year five | 19,310 | 0 | |
| Prior | 0 | 0 | |
| Revolving Loans Amortized Cost | 0 | 0 | |
| Total | 71,494 | 99,164 | |
| Gross current period charge-offs, originated, total | 0 | 0 | |
| Commercial real estate loans | Construction | Pass and Watch | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 13,915 | 13,138 | |
| Financing receivable, originated, year two | 7,661 | 24,403 | |
| Financing receivable, originated, year three | 17,794 | 19,521 | |
| Financing receivable, originated, year four | 0 | 29,512 | |
| Financing receivable, originated, year five | 19,310 | 0 | |
| Prior | 0 | 0 | |
| Revolving Loans Amortized Cost | 0 | 0 | |
| Total | 58,680 | 86,574 | |
| Commercial real estate loans | Construction | Special Mention | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 0 | 12,590 | |
| Financing receivable, originated, year two | 12,814 | 0 | |
| Financing receivable, originated, year three | 0 | 0 | |
| Financing receivable, originated, year four | 0 | 0 | |
| Financing receivable, originated, year five | 0 | 0 | |
| Prior | 0 | 0 | |
| Revolving Loans Amortized Cost | 0 | 0 | |
| Total | 12,814 | 12,590 | |
| Residential loans | Home equity | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 82 | 0 | |
| Financing receivable, originated, year two | 0 | 0 | |
| Financing receivable, originated, year three | 0 | 0 | |
| Financing receivable, originated, year four | 0 | 0 | |
| Financing receivable, originated, year five | 0 | 0 | |
| Prior | 941 | 1,103 | |
| Revolving Loans Amortized Cost | 85,771 | 80,984 | |
| Total | 86,794 | 82,087 | |
| Gross current period charge-offs, originated, total | 0 | 0 | |
| Residential loans | Home equity | Pass and Watch | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 0 | 0 | |
| Financing receivable, originated, year two | 0 | 0 | |
| Financing receivable, originated, year three | 0 | 0 | |
| Financing receivable, originated, year four | 0 | 0 | |
| Financing receivable, originated, year five | 0 | 0 | |
| Prior | 764 | 734 | |
| Revolving Loans Amortized Cost | 85,149 | 80,773 | |
| Total | 85,913 | 81,507 | |
| Residential loans | Home equity | Substandard | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 82 | 0 | |
| Financing receivable, originated, year two | 0 | 0 | |
| Financing receivable, originated, year three | 0 | 0 | |
| Financing receivable, originated, year four | 0 | 0 | |
| Financing receivable, originated, year five | 0 | 0 | |
| Prior | 177 | 369 | |
| Revolving Loans Amortized Cost | 622 | 211 | |
| Total | 881 | 580 | |
| Residential loans | Other residential | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 0 | 17,861 | |
| Financing receivable, originated, year two | 17,765 | 20,114 | |
| Financing receivable, originated, year three | 20,010 | 13,390 | |
| Financing receivable, originated, year four | 13,295 | 25,637 | |
| Financing receivable, originated, year five | 25,462 | 20,935 | |
| Prior | 36,947 | 20,571 | |
| Revolving Loans Amortized Cost | 0 | 0 | |
| Total | 113,479 | 118,508 | |
| Gross current period charge-offs, originated, total | 0 | 0 | |
| Residential loans | Other residential | Pass and Watch | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 0 | 17,861 | |
| Financing receivable, originated, year two | 17,765 | 20,114 | |
| Financing receivable, originated, year three | 20,010 | 13,390 | |
| Financing receivable, originated, year four | 13,295 | 25,637 | |
| Financing receivable, originated, year five | 25,462 | 20,935 | |
| Prior | 36,947 | 20,571 | |
| Revolving Loans Amortized Cost | 0 | 0 | |
| Total | 113,479 | 118,508 | |
| Consumer loans | Installment and other consumer loans | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 3,379 | 22,038 | |
| Financing receivable, originated, year two | 20,119 | 14,528 | |
| Financing receivable, originated, year three | 13,769 | 10,632 | |
| Financing receivable, originated, year four | 10,270 | 4,687 | |
| Financing receivable, originated, year five | 4,489 | 5,300 | |
| Prior | 14,078 | 9,399 | |
| Revolving Loans Amortized Cost | 1,003 | 1,061 | |
| Total | 67,107 | 67,645 | |
| Gross current period charge-offs, originated, year one | 0 | ||
| Gross current period charge-offs, originated, year two | (14) | ||
| Gross current period charge-offs, originated, year three | 0 | ||
| Gross current period charge-offs, originated, year four | (3) | ||
| Gross current period charge-offs, originated, year five | 0 | ||
| Gross current period charge-offs, originated, prior | 0 | ||
| Gross current period charge-offs, originated, revolving loans amortized cost | 0 | ||
| Gross current period charge-offs, originated, total | (17) | $ (11) | |
| Consumer loans | Installment and other consumer loans | Pass and Watch | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 3,379 | 22,038 | |
| Financing receivable, originated, year two | 20,119 | 14,528 | |
| Financing receivable, originated, year three | 13,769 | 10,632 | |
| Financing receivable, originated, year four | 10,129 | 4,687 | |
| Financing receivable, originated, year five | 4,489 | 5,300 | |
| Prior | 14,078 | 9,399 | |
| Revolving Loans Amortized Cost | 1,003 | 1,061 | |
| Total | 66,966 | $ 67,645 | |
| Consumer loans | Installment and other consumer loans | Substandard | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Financing receivable, originated, year one | 0 | ||
| Financing receivable, originated, year two | 0 | ||
| Financing receivable, originated, year three | 0 | ||
| Financing receivable, originated, year four | 141 | ||
| Financing receivable, originated, year five | 0 | ||
| Prior | 0 | ||
| Revolving Loans Amortized Cost | 0 | ||
| Total | $ 141 | ||
Loans and Allowance for Credit Losses on Loans - Schedule of Loans Outstanding and Aging Analysis (Details) |
3 Months Ended | ||
|---|---|---|---|
|
Mar. 31, 2024
USD ($)
loan
|
Mar. 31, 2023
USD ($)
|
Dec. 31, 2023
USD ($)
loan
|
|
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | $ 2,054,963,000 | $ 2,073,720,000 | |
| Number of loans 90 days past due and still accruing | loan | 0 | ||
| Financing receivable, nonaccrual, earning interest on cash basis | 0 | $ 0 | |
| Nonaccrual interest income reversal | 10,000 | $ 16,000 | |
| Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 2,054,963,000 | 2,073,720,000 | |
| Non-accrual loans | 6,295,000 | 7,992,000 | |
| Non-accrual loans with no allowance | 1,902,000 | 3,091,000 | |
| Total past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 13,257,000 | 7,664,000 | |
| 30-59 days past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 2,406,000 | 3,930,000 | |
| 60-89 days past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 390,000 | 2,274,000 | |
| 90 days or more past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 10,461,000 | 1,460,000 | |
| Current | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 2,041,706,000 | 2,066,056,000 | |
| Commercial loans | Commercial and industrial | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 150,896,000 | 153,750,000 | |
| Commercial loans | Commercial and industrial | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 150,896,000 | 153,750,000 | |
| Non-accrual loans | 2,220,000 | 4,008,000 | |
| Non-accrual loans with no allowance | 0 | 1,311,000 | |
| Commercial loans | Commercial and industrial | Total past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 432,000 | 4,371,000 | |
| Commercial loans | Commercial and industrial | 30-59 days past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 13,000 | 2,991,000 | |
| Commercial loans | Commercial and industrial | 60-89 days past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 390,000 | 69,000 | |
| Commercial loans | Commercial and industrial | 90 days or more past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 29,000 | 1,311,000 | |
| Commercial loans | Commercial and industrial | Current | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 150,464,000 | 149,379,000 | |
| Commercial real estate loans | Commercial owner-occupied | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 328,560,000 | 333,181,000 | |
| Commercial real estate loans | Commercial owner-occupied | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 328,560,000 | 333,181,000 | |
| Non-accrual loans | 416,000 | 434,000 | |
| Non-accrual loans with no allowance | 416,000 | 434,000 | |
| Commercial real estate loans | Commercial owner-occupied | Total past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 241,000 | 767,000 | |
| Commercial real estate loans | Commercial owner-occupied | 30-59 days past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 101,000 | 618,000 | |
| Commercial real estate loans | Commercial owner-occupied | 60-89 days past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 0 | 0 | |
| Commercial real estate loans | Commercial owner-occupied | 90 days or more past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 140,000 | 149,000 | |
| Commercial real estate loans | Commercial owner-occupied | Current | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 328,319,000 | 332,414,000 | |
| Commercial real estate loans | Commercial non-owner occupied | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 1,236,633,000 | 1,219,385,000 | |
| Commercial real estate loans | Commercial non-owner occupied | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 1,236,633,000 | 1,219,385,000 | |
| Non-accrual loans | 3,045,000 | 3,081,000 | |
| Non-accrual loans with no allowance | 872,000 | 877,000 | |
| Commercial real estate loans | Commercial non-owner occupied | Total past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 11,164,000 | 2,204,000 | |
| Commercial real estate loans | Commercial non-owner occupied | 30-59 days past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 872,000 | 0 | |
| Commercial real estate loans | Commercial non-owner occupied | 60-89 days past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | $ 0 | 2,204,000 | |
| Commercial real estate loans | Commercial non-owner occupied | 90 days or more past due | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Number of loans 90 days past due and still accruing | loan | 1 | ||
| Commercial real estate loans | Commercial non-owner occupied | 90 days or more past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | $ 10,292,000 | 0 | |
| Commercial real estate loans | Commercial non-owner occupied | Current | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 1,225,469,000 | 1,217,181,000 | |
| Commercial real estate loans | Construction | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 71,494,000 | 99,164,000 | |
| Commercial real estate loans | Construction | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 71,494,000 | 99,164,000 | |
| Non-accrual loans | 0 | 0 | |
| Non-accrual loans with no allowance | 0 | 0 | |
| Commercial real estate loans | Construction | Total past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 1,057,000 | 0 | |
| Commercial real estate loans | Construction | 30-59 days past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 1,057,000 | 0 | |
| Commercial real estate loans | Construction | 60-89 days past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 0 | 0 | |
| Commercial real estate loans | Construction | 90 days or more past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 0 | 0 | |
| Commercial real estate loans | Construction | Current | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 70,437,000 | 99,164,000 | |
| Residential loans | Home equity | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 86,794,000 | 82,087,000 | |
| Residential loans | Home equity | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 86,794,000 | 82,087,000 | |
| Non-accrual loans | 473,000 | 469,000 | |
| Non-accrual loans with no allowance | 473,000 | 469,000 | |
| Residential loans | Home equity | Total past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 360,000 | 43,000 | |
| Residential loans | Home equity | 30-59 days past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 360,000 | 43,000 | |
| Residential loans | Home equity | 60-89 days past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 0 | 0 | |
| Residential loans | Home equity | 90 days or more past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 0 | 0 | |
| Residential loans | Home equity | Current | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 86,434,000 | 82,044,000 | |
| Residential loans | Other residential | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 113,479,000 | 118,508,000 | |
| Residential loans | Other residential | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 113,479,000 | 118,508,000 | |
| Non-accrual loans | 0 | 0 | |
| Non-accrual loans with no allowance | 0 | 0 | |
| Residential loans | Other residential | Total past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 0 | 83,000 | |
| Residential loans | Other residential | 30-59 days past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 0 | 83,000 | |
| Residential loans | Other residential | 60-89 days past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 0 | 0 | |
| Residential loans | Other residential | 90 days or more past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 0 | 0 | |
| Residential loans | Other residential | Current | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 113,479,000 | 118,425,000 | |
| Consumer loans | Installment and other consumer loans | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 67,107,000 | 67,645,000 | |
| Consumer loans | Installment and other consumer loans | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 67,107,000 | 67,645,000 | |
| Non-accrual loans | 141,000 | 0 | |
| Non-accrual loans with no allowance | 141,000 | 0 | |
| Consumer loans | Installment and other consumer loans | Total past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 3,000 | 196,000 | |
| Consumer loans | Installment and other consumer loans | 30-59 days past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 3,000 | 195,000 | |
| Consumer loans | Installment and other consumer loans | 60-89 days past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 0 | 1,000 | |
| Consumer loans | Installment and other consumer loans | 90 days or more past due | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | 0 | 0 | |
| Consumer loans | Installment and other consumer loans | Current | Financial asset, other than financial asset acquired with credit deterioration | |||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
| Loans, at amortized cost | $ 67,104,000 | $ 67,449,000 | |
Loans and Allowance for Credit Losses on Loans - Schedule of Collateral-Dependent Non-Accrual Loans (Details) - USD ($) |
Mar. 31, 2024 |
Dec. 31, 2023 |
Mar. 31, 2023 |
Dec. 31, 2022 |
|---|---|---|---|---|
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Allowance for credit losses | $ 25,501,000 | $ 25,172,000 | $ 23,330,000 | $ 22,983,000 |
| Nonaccrual collateral dependent loans in process of foreclosure | $ 0 | $ 0 | ||
| Weighted average ratio of loans value to collateral dependent loans value | 82.00% | 70.00% | ||
| Collateral Pledged | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | $ 4,076,000 | $ 5,295,000 | ||
| Allowance for credit losses | 496,000 | 408,000 | ||
| Commercial Real Estate | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 3,462,000 | 4,826,000 | ||
| Residential Real Estate | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 473,000 | 469,000 | ||
| Blanket Lien | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 0 | 0 | ||
| Other | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 141,000 | 0 | ||
| Commercial loans | Commercial and industrial | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Allowance for credit losses | 1,727,000 | 1,712,000 | 1,941,000 | 1,794,000 |
| Commercial loans | Commercial and industrial | Collateral Pledged | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 1,311,000 | |||
| Allowance for credit losses | 0 | |||
| Commercial loans | Commercial and industrial | Commercial Real Estate | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 1,311,000 | |||
| Commercial loans | Commercial and industrial | Residential Real Estate | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 0 | |||
| Commercial loans | Commercial and industrial | Blanket Lien | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 0 | |||
| Commercial loans | Commercial and industrial | Other | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 0 | |||
| Commercial real estate loans | Commercial owner-occupied | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Allowance for credit losses | 2,500,000 | 2,476,000 | 2,640,000 | 2,487,000 |
| Commercial real estate loans | Commercial owner-occupied | Collateral Pledged | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 416,000 | 434,000 | ||
| Allowance for credit losses | 0 | 0 | ||
| Commercial real estate loans | Commercial owner-occupied | Commercial Real Estate | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 416,000 | 434,000 | ||
| Commercial real estate loans | Commercial owner-occupied | Residential Real Estate | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 0 | 0 | ||
| Commercial real estate loans | Commercial owner-occupied | Blanket Lien | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 0 | 0 | ||
| Commercial real estate loans | Commercial owner-occupied | Other | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 0 | 0 | ||
| Commercial real estate loans | Commercial non-owner occupied | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Allowance for credit losses | 15,704,000 | 14,933,000 | 12,701,000 | 12,676,000 |
| Commercial real estate loans | Commercial non-owner occupied | Collateral Pledged | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 3,046,000 | 3,081,000 | ||
| Allowance for credit losses | 496,000 | 408,000 | ||
| Commercial real estate loans | Commercial non-owner occupied | Commercial Real Estate | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 3,046,000 | 3,081,000 | ||
| Commercial real estate loans | Commercial non-owner occupied | Residential Real Estate | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 0 | 0 | ||
| Commercial real estate loans | Commercial non-owner occupied | Blanket Lien | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 0 | |||
| Commercial real estate loans | Commercial non-owner occupied | Other | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 0 | 0 | ||
| Residential loans | Home equity | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Allowance for credit losses | 627,000 | 552,000 | 538,000 | 558,000 |
| Residential loans | Home equity | Collateral Pledged | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 473,000 | 469,000 | ||
| Allowance for credit losses | 0 | 0 | ||
| Residential loans | Home equity | Commercial Real Estate | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 0 | 0 | ||
| Residential loans | Home equity | Residential Real Estate | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 473,000 | 469,000 | ||
| Residential loans | Home equity | Blanket Lien | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 0 | 0 | ||
| Residential loans | Home equity | Other | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 0 | 0 | ||
| Consumer loans | Installment and other consumer loans | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Allowance for credit losses | 920,000 | $ 976,000 | $ 882,000 | $ 868,000 |
| Consumer loans | Installment and other consumer loans | Collateral Pledged | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 141,000 | |||
| Allowance for credit losses | 0 | |||
| Consumer loans | Installment and other consumer loans | Commercial Real Estate | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 0 | |||
| Consumer loans | Installment and other consumer loans | Residential Real Estate | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 0 | |||
| Consumer loans | Installment and other consumer loans | Blanket Lien | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | 0 | |||
| Consumer loans | Installment and other consumer loans | Other | ||||
| Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
| Non-accrual loans | $ 141,000 |
Loans and Allowance for Credit Losses on Loans - Schedule of Amortized Cost Of Loan Modifications (Details) $ in Thousands |
3 Months Ended |
|---|---|
|
Mar. 31, 2024
USD ($)
| |
| Financing Receivable, Troubled Debt Restructuring [Line Items] | |
| Total Modifications | $ 2,273 |
| Term Extension | |
| Financing Receivable, Troubled Debt Restructuring [Line Items] | |
| Total Modifications | 2,273 |
| Commercial and industrial | Commercial loans | |
| Financing Receivable, Troubled Debt Restructuring [Line Items] | |
| Total Modifications | 2,191 |
| Commercial and industrial | Term Extension | Commercial loans | |
| Financing Receivable, Troubled Debt Restructuring [Line Items] | |
| Total Modifications | $ 2,191 |
| Percent of Portfolio Class Total | 1.50% |
| Home equity | Residential loans | |
| Financing Receivable, Troubled Debt Restructuring [Line Items] | |
| Total Modifications | $ 82 |
| Home equity | Term Extension | Residential loans | |
| Financing Receivable, Troubled Debt Restructuring [Line Items] | |
| Total Modifications | $ 82 |
| Percent of Portfolio Class Total | 0.10% |
Loans and Allowance for Credit Losses on Loans - Schedule of Amortized Cost Of Loans Modifications (Details) - Term Extension |
3 Months Ended |
|---|---|
Mar. 31, 2024 | |
| Commercial and industrial | Commercial loans | |
| Financing Receivable, Troubled Debt Restructuring [Line Items] | |
| Weighted-Average Term Extension (in years) | 3 months 18 days |
| Home equity | Residential loans | |
| Financing Receivable, Troubled Debt Restructuring [Line Items] | |
| Weighted-Average Term Extension (in years) | 15 years |
Loans and Allowance for Credit Losses on Loans - Schedule of Amortized Cost Of Loan (Details) $ in Thousands |
3 Months Ended |
|---|---|
|
Mar. 31, 2024
USD ($)
| |
| Financing Receivable, Troubled Debt Restructuring [Line Items] | |
| Total Modifications | $ 2,273 |
| Non-Accrual | 2,273 |
| Total past due | |
| Financing Receivable, Troubled Debt Restructuring [Line Items] | |
| Total Modifications | 2,273 |
| 30-59 days past due | |
| Financing Receivable, Troubled Debt Restructuring [Line Items] | |
| Total Modifications | 0 |
| 60-89 days past due | |
| Financing Receivable, Troubled Debt Restructuring [Line Items] | |
| Total Modifications | 0 |
| 90 days or more past due | |
| Financing Receivable, Troubled Debt Restructuring [Line Items] | |
| Total Modifications | 0 |
| Commercial loans | Commercial and industrial | |
| Financing Receivable, Troubled Debt Restructuring [Line Items] | |
| Total Modifications | 2,191 |
| Non-Accrual | 2,191 |
| Commercial loans | Commercial and industrial | Total past due | |
| Financing Receivable, Troubled Debt Restructuring [Line Items] | |
| Total Modifications | 2,191 |
| Commercial loans | Commercial and industrial | 30-59 days past due | |
| Financing Receivable, Troubled Debt Restructuring [Line Items] | |
| Total Modifications | 0 |
| Commercial loans | Commercial and industrial | 60-89 days past due | |
| Financing Receivable, Troubled Debt Restructuring [Line Items] | |
| Total Modifications | 0 |
| Commercial loans | Commercial and industrial | 90 days or more past due | |
| Financing Receivable, Troubled Debt Restructuring [Line Items] | |
| Total Modifications | 0 |
| Residential loans | Home equity | |
| Financing Receivable, Troubled Debt Restructuring [Line Items] | |
| Total Modifications | 82 |
| Non-Accrual | 82 |
| Residential loans | Home equity | Total past due | |
| Financing Receivable, Troubled Debt Restructuring [Line Items] | |
| Total Modifications | 82 |
| Residential loans | Home equity | 30-59 days past due | |
| Financing Receivable, Troubled Debt Restructuring [Line Items] | |
| Total Modifications | 0 |
| Residential loans | Home equity | 90 days or more past due | |
| Financing Receivable, Troubled Debt Restructuring [Line Items] | |
| Total Modifications | $ 0 |
Loans and Allowance for Credit Losses on Loans - Schedule of Allocation of the Allowance for Credit Losses on Loans (Details) - USD ($) $ in Thousands |
Mar. 31, 2024 |
Dec. 31, 2023 |
Mar. 31, 2023 |
Dec. 31, 2022 |
|---|---|---|---|---|
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | $ 25,501 | $ 25,172 | $ 23,330 | $ 22,983 |
| Modeled expected credit losses | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 12,013 | 11,467 | ||
| Qualitative adjustments | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 12,136 | 12,284 | ||
| Specific allocations | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 1,352 | 1,421 | ||
| Commercial loans | Commercial and industrial | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 1,727 | 1,712 | 1,941 | 1,794 |
| Commercial loans | Commercial and industrial | Modeled expected credit losses | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 940 | 897 | ||
| Commercial loans | Commercial and industrial | Qualitative adjustments | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 628 | 622 | ||
| Commercial loans | Commercial and industrial | Specific allocations | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 159 | 193 | ||
| Commercial real estate loans | Commercial owner-occupied | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 2,500 | 2,476 | 2,640 | 2,487 |
| Commercial real estate loans | Commercial owner-occupied | Modeled expected credit losses | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 1,326 | 1,270 | ||
| Commercial real estate loans | Commercial owner-occupied | Qualitative adjustments | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 1,174 | 1,205 | ||
| Commercial real estate loans | Commercial owner-occupied | Specific allocations | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 0 | 1 | ||
| Commercial real estate loans | Commercial non-owner occupied | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 15,704 | 14,933 | 12,701 | 12,676 |
| Commercial real estate loans | Commercial non-owner occupied | Modeled expected credit losses | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 7,744 | 7,380 | ||
| Commercial real estate loans | Commercial non-owner occupied | Qualitative adjustments | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 6,767 | 6,327 | ||
| Commercial real estate loans | Commercial non-owner occupied | Specific allocations | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 1,193 | 1,226 | ||
| Commercial real estate loans | Construction | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 1,282 | 1,832 | 2,019 | 1,937 |
| Commercial real estate loans | Construction | Modeled expected credit losses | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 119 | 185 | ||
| Commercial real estate loans | Construction | Qualitative adjustments | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 1,163 | 1,647 | ||
| Commercial real estate loans | Construction | Specific allocations | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 0 | 0 | ||
| Residential loans | Home equity | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 627 | 552 | 538 | 558 |
| Residential loans | Home equity | Modeled expected credit losses | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 559 | 482 | ||
| Residential loans | Home equity | Qualitative adjustments | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 68 | 70 | ||
| Residential loans | Home equity | Specific allocations | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 0 | 0 | ||
| Residential loans | Other residential | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 692 | 653 | 577 | 595 |
| Residential loans | Other residential | Modeled expected credit losses | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 670 | 619 | ||
| Residential loans | Other residential | Qualitative adjustments | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 22 | 33 | ||
| Residential loans | Other residential | Specific allocations | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 0 | 1 | ||
| Consumer loans | Installment and other consumer loans | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 920 | 976 | 882 | 868 |
| Consumer loans | Installment and other consumer loans | Modeled expected credit losses | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 655 | 634 | ||
| Consumer loans | Installment and other consumer loans | Qualitative adjustments | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 265 | 342 | ||
| Consumer loans | Installment and other consumer loans | Specific allocations | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 0 | 0 | ||
| Unallocated | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 2,049 | 2,038 | $ 2,032 | $ 2,068 |
| Unallocated | Modeled expected credit losses | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 0 | 0 | ||
| Unallocated | Qualitative adjustments | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | 2,049 | 2,038 | ||
| Unallocated | Specific allocations | ||||
| Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
| Allowance for credit losses | $ 0 | $ 0 |
Loans and Allowance for Credit Losses on Loans - Schedule of Allowance for Credit Losses on Loans (Details) - USD ($) $ in Thousands |
3 Months Ended | ||
|---|---|---|---|
Mar. 31, 2024 |
Dec. 31, 2023 |
Mar. 31, 2023 |
|
| Allowance for Loan and Lease Losses [Roll Forward] | |||
| Beginning balance | $ 25,172 | $ 22,983 | |
| (Reversal) Provision | 350 | $ 1,300 | 350 |
| (Charge-offs) | (21) | (14) | |
| Recoveries | 0 | 11 | |
| Ending balance | 25,501 | 25,172 | 23,330 |
| Commercial loans | Commercial and industrial | |||
| Allowance for Loan and Lease Losses [Roll Forward] | |||
| Beginning balance | 1,712 | 1,794 | |
| (Reversal) Provision | 19 | 147 | |
| (Charge-offs) | (4) | (3) | |
| Recoveries | 0 | 3 | |
| Ending balance | 1,727 | 1,712 | 1,941 |
| Commercial real estate loans | Commercial owner-occupied | |||
| Allowance for Loan and Lease Losses [Roll Forward] | |||
| Beginning balance | 2,476 | 2,487 | |
| (Reversal) Provision | 24 | 153 | |
| (Charge-offs) | 0 | 0 | |
| Recoveries | 0 | 0 | |
| Ending balance | 2,500 | 2,476 | 2,640 |
| Commercial real estate loans | Commercial non-owner occupied | |||
| Allowance for Loan and Lease Losses [Roll Forward] | |||
| Beginning balance | 14,933 | 12,676 | |
| (Reversal) Provision | 771 | 25 | |
| (Charge-offs) | 0 | 0 | |
| Recoveries | 0 | 0 | |
| Ending balance | 15,704 | 14,933 | 12,701 |
| Commercial real estate loans | Construction | |||
| Allowance for Loan and Lease Losses [Roll Forward] | |||
| Beginning balance | 1,832 | 1,937 | |
| (Reversal) Provision | (550) | 74 | |
| (Charge-offs) | 0 | 0 | |
| Recoveries | 0 | 8 | |
| Ending balance | 1,282 | 1,832 | 2,019 |
| Residential loans | Home equity | |||
| Allowance for Loan and Lease Losses [Roll Forward] | |||
| Beginning balance | 552 | 558 | |
| (Reversal) Provision | 75 | (20) | |
| (Charge-offs) | 0 | 0 | |
| Recoveries | 0 | 0 | |
| Ending balance | 627 | 552 | 538 |
| Residential loans | Other residential | |||
| Allowance for Loan and Lease Losses [Roll Forward] | |||
| Beginning balance | 653 | 595 | |
| (Reversal) Provision | 39 | (18) | |
| (Charge-offs) | 0 | 0 | |
| Recoveries | 0 | 0 | |
| Ending balance | 692 | 653 | 577 |
| Consumer loans | Installment and other consumer loans | |||
| Allowance for Loan and Lease Losses [Roll Forward] | |||
| Beginning balance | 976 | 868 | |
| (Reversal) Provision | (39) | 25 | |
| (Charge-offs) | (17) | (11) | |
| Recoveries | 0 | 0 | |
| Ending balance | 920 | 976 | 882 |
| Unallocated | |||
| Allowance for Loan and Lease Losses [Roll Forward] | |||
| Beginning balance | 2,038 | 2,068 | |
| (Reversal) Provision | 11 | (36) | |
| (Charge-offs) | 0 | 0 | |
| Recoveries | 0 | 0 | |
| Ending balance | $ 2,049 | $ 2,038 | $ 2,032 |
Loans and Allowance for Credit Losses on Loans - Pledged Loans (Details) - USD ($) $ in Millions |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Other residential | Federal Reserve Bank | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Collateral pledged | $ 108.5 | $ 110.4 |
| Federal Home Loan Bank of San Francisco | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Collateral pledged | $ 1,299.0 | $ 1,288.0 |
Loans and Allowance for Credit Losses on Loans - Related Party (Details) - Related Party - USD ($) $ in Thousands |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Related Party Transaction [Line Items] | ||
| Related party loans | $ 5,800 | $ 5,800 |
| Undisbursed commitment to related parties | $ 212 | $ 212 |
Borrowings and Other Obligations - Lines of Credit (Details) - Line of credit - USD ($) $ in Millions |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| FHLB short-term borrowings | ||
| Line of Credit Facility [Line Items] | ||
| Lines of credit | $ 951.2 | $ 1,009.0 |
| Federal reserve bank of san francisco | FRBSF short-term borrowings under the BTFP | ||
| Line of Credit Facility [Line Items] | ||
| Lines of credit | 350.0 | |
| Federal reserve line of credit | ||
| Line of Credit Facility [Line Items] | ||
| Lines of credit | 64.0 | |
| Federal reserve line of credit | FRBSF short-term borrowings under the BTFP | ||
| Line of Credit Facility [Line Items] | ||
| Lines of credit | 270.2 | |
| Unsecured debt | FRBSF federal funds purchased | ||
| Line of Credit Facility [Line Items] | ||
| Lines of credit | $ 125.0 | $ 135.0 |
Borrowings and Other Obligations- Other Obligations (Details) - USD ($) $ in Thousands |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Debt Disclosure [Abstract] | ||
| Finance lease liabilities | $ 260 | $ 298 |
| Finance lease, liability, statement of financial position [Extensible List] | Debt and Lease Obligation | Debt and Lease Obligation |
Borrowings and Other Obligations - Schedule of Borrowings (Details) - USD ($) $ in Thousands |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Line of Credit Facility [Line Items] | ||
| Finance lease liabilities | $ 260 | $ 298 |
| Borrowings and other obligations | $ 260 | $ 26,298 |
| Weighted Average Rate | 2.14% | 1.88% |
| Weighted Average Rate | 2.14% | 5.26% |
| Line of credit | Federal funds lines of credit | ||
| Line of Credit Facility [Line Items] | ||
| Carrying Value | $ 0 | $ 0 |
| Weighted Average Rate | 0.00% | 0.00% |
| Line of credit | FRBSF federal funds purchased | ||
| Line of Credit Facility [Line Items] | ||
| Carrying Value | $ 0 | $ 0 |
| Weighted Average Rate | 0.00% | 0.00% |
| Line of credit | FHLB short-term borrowings | ||
| Line of Credit Facility [Line Items] | ||
| Carrying Value | $ 0 | $ 0 |
| Weighted Average Rate | 0.00% | 0.00% |
| Line of credit | FRBSF short-term borrowings under the BTFP | ||
| Line of Credit Facility [Line Items] | ||
| Carrying Value | $ 0 | $ 26,000 |
| Weighted Average Rate | 0.00% | 5.30% |
Stockholders' Equity - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions |
3 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|
Apr. 25, 2024 |
Jan. 25, 2024 |
Mar. 31, 2024 |
Dec. 31, 2023 |
Jul. 21, 2023 |
|
| Class of Stock [Line Items] | |||||
| Dividends declared per common share (in usd per share) | $ 0.25 | ||||
| Subsequent event | |||||
| Class of Stock [Line Items] | |||||
| Dividends declared per common share (in usd per share) | $ 0.25 | ||||
| Common Stock | |||||
| Class of Stock [Line Items] | |||||
| Share repurchase program, amount approved to repurchase | $ 25.0 | ||||
| Stock repurchased, including commissions (in shares) | 0 | 0 | |||
| Performance-based stock awards | |||||
| Class of Stock [Line Items] | |||||
| Vesting period of performance-based stock awards | 3 years | ||||
| Performance-based stock awards | Minimum | |||||
| Class of Stock [Line Items] | |||||
| Vesting percentage of performance-based awards | 0.00% | ||||
| Performance-based stock awards | Maximum | |||||
| Class of Stock [Line Items] | |||||
| Vesting percentage of performance-based awards | 200.00% |
Stockholders' Equity - Schedule of Cashless Exercise Information (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
| Equity [Abstract] | ||
| Number of shares withheld (in shares) | 3,338 | 2,847 |
| Amount of shares withheld for tax withholding and exercise of options | $ 55 | $ 82 |
| Weighted-average price (usd per share) | $ 16.62 | $ 28.74 |
Commitments and Contingent Liabilities - Schedule of Undrawn Loan Commitments and Standby Letters of Credit (Details) - USD ($) $ in Thousands |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Total unfunded loan commitments and standby letters of credit | ||
| Other Commitments [Line Items] | ||
| Total unfunded loan commitments and standby letters of credit | $ 489,444 | $ 505,150 |
| Commercial lines of credit | ||
| Other Commitments [Line Items] | ||
| Total unfunded loan commitments and standby letters of credit | 250,602 | 259,989 |
| Revolving home equity lines | ||
| Other Commitments [Line Items] | ||
| Total unfunded loan commitments and standby letters of credit | 216,387 | 218,935 |
| Undisbursed construction loans | ||
| Other Commitments [Line Items] | ||
| Total unfunded loan commitments and standby letters of credit | 10,176 | 13,943 |
| Personal and other lines of credit | ||
| Other Commitments [Line Items] | ||
| Total unfunded loan commitments and standby letters of credit | 9,132 | 9,136 |
| Standby letters of credit | ||
| Other Commitments [Line Items] | ||
| Total unfunded loan commitments and standby letters of credit | $ 3,147 | $ 3,147 |
Commitments and Contingent Liabilities - Narrative (Details) - USD ($) |
3 Months Ended | ||
|---|---|---|---|
Mar. 31, 2024 |
Dec. 31, 2023 |
Mar. 31, 2023 |
|
| Loss Contingencies [Line Items] | |||
| Reversal of credit losses on unfunded loan commitments | $ 0 | $ 0 | $ 174,000 |
| Unfunded loan commitments | $ 37,400,000 | ||
| Minimum | |||
| Loss Contingencies [Line Items] | |||
| Weighted average remaining term (in years) | 30 days | ||
| Finance lease, initial contract terms (in years) | 3 years | ||
| Maximum | |||
| Loss Contingencies [Line Items] | |||
| Weighted average remaining term (in years) | 18 years 5 months | ||
| Finance lease, initial contract terms (in years) | 5 years | ||
| Interest payable and other liabilities | Total unfunded loan commitments and standby letters of credit | |||
| Loss Contingencies [Line Items] | |||
| Allowance for off balance sheet commitments | $ 1,100,000 | $ 1,100,000 | |
Commitments and Contingent Liabilities - Schedule of Operating and Finance Lease Right-of-Use Assets and Lease Liabilities (Details) - USD ($) $ in Thousands |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Operating leases: | ||
| Operating lease right-of-use assets | $ 21,553 | $ 20,316 |
| Operating lease liabilities | $ 24,150 | $ 22,906 |
| Finance leases: | ||
| Finance lease, right-of-use asset, statement of financial position [Extensible List] | Bank premises and equipment, net | Bank premises and equipment, net |
| Finance lease right-of-use assets | $ 608 | $ 608 |
| Accumulated amortization | (356) | (319) |
| Finance lease right-of-use assets, net | 252 | 289 |
| Finance lease liabilities | $ 260 | $ 298 |
Commitments and Contingent Liabilities - Schedule of Noncash Investing and Financing Activities (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
| Commitments and Contingencies Disclosure [Abstract] | ||
| Right-of-use assets obtained in exchange for operating lease liabilities | $ 2,417 | $ 0 |
Commitments and Contingent Liabilities - Schedule of Lease Cost (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
| Commitments and Contingencies Disclosure [Abstract] | ||
| Operating lease cost | $ 1,318 | $ 1,610 |
| Finance lease cost: | ||
| Amortization of right-of-use assets | 37 | 37 |
| Interest on finance lease liabilities | 1 | 2 |
| Total finance lease cost | 38 | 39 |
| Total lease cost | $ 1,356 | $ 1,649 |
Commitments and Contingent Liabilities - Schedule of Operating and Finance Lease Liability Maturity Schedule (Details) - USD ($) $ in Thousands |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Operating Leases | ||
| 2024 | $ 3,630 | |
| 2025 | 4,295 | |
| 2026 | 3,561 | |
| 2027 | 3,291 | |
| 2028 | 2,910 | |
| Thereafter | 9,856 | |
| Total minimum lease payments | 27,543 | |
| Amounts representing interest (present value discount) | (3,393) | |
| Present value of net minimum lease payments (lease liability) | $ 24,150 | $ 22,906 |
| Weighted average remaining term (in years) | 8 years | |
| Weighted average discount rate | 2.72% | |
| Finance Leases | ||
| 2024 | $ 117 | |
| 2025 | 108 | |
| 2026 | 37 | |
| 2027 | 5 | |
| 2028 | 0 | |
| Thereafter | 0 | |
| Total minimum lease payments | 267 | |
| Amounts representing interest (present value discount) | (7) | |
| Present value of net minimum lease payments (lease liability) | $ 260 | $ 298 |
| Weighted average remaining term (in years) | 2 years | |
| Weighted average discount rate | 2.14% |
Derivative Financial Instruments and Hedging Activities - Narrative (Details) - Interest rate swap $ in Millions |
Jul. 07, 2023
USD ($)
|
Mar. 31, 2024
interest_rate_swap
|
|---|---|---|
| Derivatives, Fair Value [Line Items] | ||
| Derivative, notional amount | $ | $ 101.8 | |
| Minimum | ||
| Derivatives, Fair Value [Line Items] | ||
| Derivative, term of contract | 2 years 6 months | |
| Maximum | ||
| Derivatives, Fair Value [Line Items] | ||
| Derivative, term of contract | 3 years | |
| Fair value hedge | Designated as hedging instrument | ||
| Derivatives, Fair Value [Line Items] | ||
| Number of instruments held | interest_rate_swap | 3 |
Derivative Financial Instruments and Hedging Activities - Schedule of Information on Derivatives (Details) - USD ($) $ in Thousands |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Derivatives, Fair Value [Line Items] | ||
| Accrued interest | $ 2,300 | $ 2,300 |
| Available For Sale Securities | ||
| Derivatives, Fair Value [Line Items] | ||
| Carrying Amounts of Hedged Assets | 108,125 | 107,181 |
| Cumulative Amounts of Fair Value Hedging Adjustments Included in the Carrying Amounts of the Hedged Assets | (142) | (1,359) |
| Loans Receivable | ||
| Derivatives, Fair Value [Line Items] | ||
| Carrying Amounts of Hedged Assets | 7,841 | 8,183 |
| Cumulative Amounts of Fair Value Hedging Adjustments Included in the Carrying Amounts of the Hedged Assets | (478) | (367) |
| Fair value hedge | ||
| Derivatives, Fair Value [Line Items] | ||
| Accrued interest | 233 | 222 |
| Fair value hedge | Designated as hedging instrument | Interest rate swap | Available For Sale Securities | ||
| Derivatives, Fair Value [Line Items] | ||
| Interest rate contracts notional amount, asset derivatives | 0 | 0 |
| Interest rate contracts notional amount, liability derivatives | 101,770 | 101,770 |
| Interest rate contracts fair value, asset derivatives | 0 | 0 |
| Interest rate contracts fair value, liability derivatives | 142 | 1,359 |
| Fair value hedge | Designated as hedging instrument | Interest rate contract | Loans Receivable | ||
| Derivatives, Fair Value [Line Items] | ||
| Interest rate contracts notional amount, asset derivatives | 8,366 | 6,441 |
| Interest rate contracts notional amount, liability derivatives | 0 | 2,157 |
| Interest rate contracts fair value, asset derivatives | 400 | 287 |
| Interest rate contracts fair value, liability derivatives | $ 0 | $ 2 |
Derivative Financial Instruments and Hedging Activities - Schedule of Interest Income (Details) - Fair value hedge - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
| Interest on Investment Securities | ||
| Derivatives, Fair Value [Line Items] | ||
| Increase (decrease) in fair value | $ 1,217 | $ 0 |
| Hedged interest earned | 206 | 0 |
| (Decrease) increase in carrying value included in the hedged loans | (1,217) | 0 |
| Net gain recognized in interest income on loans | 206 | 0 |
| Interest and Fees on Loans | ||
| Derivatives, Fair Value [Line Items] | ||
| Increase (decrease) in fair value | 115 | (221) |
| Hedged interest earned | 54 | 51 |
| (Decrease) increase in carrying value included in the hedged loans | (110) | 221 |
| Decrease in value of yield maintenance agreement | (2) | (2) |
| Net gain recognized in interest income on loans | $ 57 | $ 49 |
Derivative Financial Instruments and Hedging Activities - Schedule of Offsetting of Assets (Details) - USD ($) $ in Thousands |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Derivatives, Fair Value [Line Items] | ||
| Gross amounts of recognized assets | $ 400 | $ 287 |
| Gross amounts offset in the statements of condition | 0 | 0 |
| Net amounts of assets presented in the statements of condition | 400 | 287 |
| Gross amounts not offset in the statements of condition, financial instruments | 0 | 0 |
| Gross amounts not offset in the statements of condition, cash collateral received | 0 | 0 |
| Net Amount | 400 | 287 |
| Counterparty | ||
| Derivatives, Fair Value [Line Items] | ||
| Gross amounts of recognized assets | 400 | 287 |
| Gross amounts offset in the statements of condition | 0 | 0 |
| Net amounts of assets presented in the statements of condition | 400 | 287 |
| Gross amounts not offset in the statements of condition, financial instruments | 0 | 0 |
| Gross amounts not offset in the statements of condition, cash collateral received | 0 | 0 |
| Net Amount | $ 400 | $ 287 |
Derivative Financial Instruments and Hedging Activities - Schedule of Offsetting of Liabilities (Details) - USD ($) $ in Thousands |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Derivatives, Fair Value [Line Items] | ||
| Gross amounts of recognized liabilities | $ 142 | $ 1,361 |
| Gross amounts offset in the statements of condition | 0 | 0 |
| Net amounts of liabilities presented in the statements of condition | 142 | 1,361 |
| Gross amounts not offset in the statements of condition, financial instruments | (142) | (287) |
| Gross amounts not offset in the statements of condition, cash collateral pledged | 0 | (330) |
| Net Amount | 0 | 744 |
| Counterparty | ||
| Derivatives, Fair Value [Line Items] | ||
| Gross amounts of recognized liabilities | 142 | 1,361 |
| Gross amounts offset in the statements of condition | 0 | 0 |
| Net amounts of liabilities presented in the statements of condition | 142 | 1,361 |
| Gross amounts not offset in the statements of condition, financial instruments | (142) | (287) |
| Gross amounts not offset in the statements of condition, cash collateral pledged | 0 | (330) |
| Net Amount | $ 0 | $ 744 |